Slashdot Mirror


The Cost of Drugs For Rare Diseases Is Threatening the US Health Care System (hbr.org)

An anonymous reader shares an article: There are 7,000 rare diseases affecting 25 million to 30 million Americans. The average drug approved under the Orphan Drug Act of 1983 (ODA), which governs rare disease approval, costs $118,820 per year. Assuming a similar cost, if a single drug were approved under the ODA for 10% of rare diseases, the total would exceed $350 billion annually -- more than 10 percent of the total amount that America spends on health care and much more than the health care costs attributable to either diabetes or Alzheimer's disease and other forms of dementia. If this seems far-fetched, consider the two drugs for treating Duchenne muscular dystrophy that the FDA approved in the last six months: eteplirsen, which is sold by Sarepta Therapeutics and costs $300,000 annually per patient, and deflazacort, which is sold by Marathon Pharmaceuticals and costs $89,000 annually per patient. However, approval of such costly drugs exposes an uncomfortable truth: scientific discovery has outpaced health care economics. [...] In the United Kingdom, the National Institute for Health and Care Excellence (NICE) determines the cost effectiveness, or value, of newly approved drugs based on their impact on quality-adjusted life years. These determinations inform the National Health System's (NHS) treatment-coverage decisions. In contrast, the FDA is prohibited from considering cost or value in its decision making, and there is no U.S. governmental equivalent of NICE.

185 of 311 comments (clear)

  1. Wait! by war4peace · · Score: 5, Insightful

    I wonder what's the markup on those drugs.
    Are they that costly to produce?

    --
    ...gis sdrawkcab (usually not responding to ACs; don't bother posting as AC)
    1. Re:Wait! by sinij · · Score: 2

      This approach will stop all industry research on rare disease moving forward. This will have to be matched by government funding to public institutions doing similar research.

      While this will be cheaper, it isn't THAT much cheaper.

    2. Re:Wait! by Gilgaron · · Score: 1

      They might since for some of these there'd be no economics of scale... it is like the difference between buying parts off the shelf versus having them machined.

    3. Re:Wait! by Luthair · · Score: 2

      While I think these are likely a rip-off, you do also need to consider R&D costs and for rarer disorders the cost spread over a smaller number of dosages.

    4. Re:Wait! by fluffernutter · · Score: 2

      Yes because it makes sense to throw all your money into a bottomless pit until you can't help anyone, rather than look for someone who will create cures at a more sustainable cost.

      --
      Laws are rules for the court, but merely a bottom bar to hit for life. Think beyond laws in your actions always.
    5. Re:Wait! by Solandri · · Score: 4, Insightful

      When it costs $2.5 billion to get FDA approval for a drug, and your potential market is a few thousand or tens of thousands of people, you have to price it that high just to recoup your costs.

      The real problem is that we have buyers (insurance and government) who will pay that price regardless of whether the drug actually provides that much value to the patients. It's a noble sentiment to believe that every life is worth saving. But practically, when you try to do that you just end up burdening society with costs which give you a negative return on investment (you're throwing away money - people's productivity that they've sent in good faith to government and to insurance companies).

    6. Re:Wait! by Jhon · · Score: 1

      "I wonder what's the markup on those drugs. Are they that costly to produce?"

      Most certainly, when you factor in the cost in R&D the cost per pill over a given period of time, the cost of FDA approval -- basically everything it takes to bring medication to market. Most people don't consider any of that -- just that when they put the powder in one end and the pill comes out the other end how much is the pill?

      By definition, rare diseases are RARE and they wont be making huge numbers of pills to spread out the total cost.

      I don't believe there is a solution other than to wait and hope newer technology will allow for the cheaper creation of new drugs. Think of it like continuing to use fossil fuels until we manage to get really good at making high efficiency solar panels and better ways to store power -- all at a good cost-point. Sooner or later we'll either run out of the resource (oil in my example, "money" for R&D for medications for rare diseases) or make the breakthroughs we need. If we dont, then we'll have some hard decisions to make...

    7. Re: Wait! by ArmoredDragon · · Score: 2, Interesting

      In other words, somebody who will work at a fraction of the price. I'm not an economist, but I suspect that kind of mindset won't attract new talent into that industry. But maybe I'm wrong.

      Though I read somewhere that 90% of these (and other) drugs are made in the US, and then sold elsewhere as an afterthought to drive additional revenue. So in other words, European health care systems get a (mostly) free ride.

      That said, it would be interesting to watch what happens internationally if the FDA was allowed to negotiate drug prices, and/or if there were price controls on drugs that have any form of market exclusivity in the US.

    8. Re: Wait! by AutodidactLabrat · · Score: 5, Interesting

      The various drug companies spend 3 1/2 x as much on advertising and marketing as research, with MOST basic research paid for by governments and sold for pennies or given away for free
      Welfare starts at the top

    9. Re:Wait! by bluefoxlucid · · Score: 1

      Gross margin? Huge.

      Net margin? It costs several billion to get drugs to market. All that FDA safety and efficacy stuff is about $310 million, from lab rat studies over 3 years to a 3-year follow-up with patients to document side-effects and efficacy once the drug is out in the market. Only about 10% of new drugs make it to market, and a lot goes into the pipeline and doesn't even make it to being a "new drug". The sunk research costs are $3-$5 billion per drug.

      For these drugs, they have to recover $3-$5 billion to break even. With a small target market, the gross margin is going to be a lot bigger to make that up. This is one of the reasons cognitive enhancement is medically ethical: something like Modafinil treats narcolepsy, but would be universally-useful to practically everyone due to its safety and efficacy as a non-addictive eugerogic (let you pull an all-nighter now and then) or study drug. The market becomes enormous, and the amount of money you can make on 60 cents per pill is ludicrous (it only costs about 11 cents to manufacture a 100mg dose). As it stands, it might cost you $12 a pill in America, although I can get it out-of-pocket for $240 for a 90-day supply from my PBM without insurance coverage.

      Drugs with broad uses tend to become cheap and generic.

    10. Re:Wait! by Luthair · · Score: 1

      Your quote is very misleading, that isn't the cost of FDA approval not even the real cost. Your article states 1.4 billion to bring to market (from nothing) then decides investors could have somehow made 1.2-billion in that period by investing - a 90% return is ludicrous over 10-years is unlikely and since its not all spent at the start of 10-years the supposed rate of return is more like 180%.

    11. Re:Wait! by epyT-R · · Score: 1

      The costs involved in their development.

    12. Re:Wait! by myowntrueself · · Score: 1

      By definition, rare diseases are RARE and they wont be making huge numbers of pills to spread out the total cost.

      Rare and yet ten times more Americans suffer from them than the margin by which Hillary 'won' the popular vote.

      And yet Democrats still whine about that so much you'd think it was a really significant portion of the US population.

      If 3 million people is enough to consider that Hillary 'really won' the election then is 30 million people enough to consider these diseases worth fighting?

      --
      In the free world the media isn't government run; the government is media run.
    13. Re:Wait! by ShanghaiBill · · Score: 1

      rather than look for someone who will create cures at a more sustainable cost.

      If you are offering BILLIONS of dollars, you don't need to "look for someone". They will find you. The fact that no one else is offering to undercut the pharma companies producing these drugs most likely means there is no excessive profit margin. The development costs are enormous, and since the diseases are rare the market is tiny, that means a high unit price.

    14. Re: Wait! by fluffernutter · · Score: 1

      The thing that's shitty about this deal is that we have to pay for it but we don't get to pick what they work on.

      --
      Laws are rules for the court, but merely a bottom bar to hit for life. Think beyond laws in your actions always.
    15. Re: Wait! by ShanghaiBill · · Score: 5, Informative

      The various drug companies spend 3 1/2 x as much on advertising and marketing as research

      The actual ratio is about 1.8 to one, but still an unreasonable amount considering all the taxpayer subsides that these companies receive. Much of that is spent marketing directly to doctors in ways that are nearly indistinguishable from just bribing them to write prescriptions.

    16. Re:Wait! by gnick · · Score: 1

      If 3 million people is enough to consider that Hillary 'really won' the election then is 30 million people enough to consider these diseases worth fighting?

      That's 25-30 million people with 7,000 different diseases. That's about 4k people per disease. They're not researching a single cure for all those 30 million people.

      WTF does this have to do with the election or number of votes cast? There's only one person still obsessed with the election results and TFA isn't about him.

      --
      He's getting rather old, but he's a good mouse.
    17. Re:Wait! by El+Cubano · · Score: 1

      ...a 90% return is ludicrous over 10-years is unlikely and since its not all spent at the start of 10-years the supposed rate of return is more like 180%.

      One word: compounding

      The reality is that using the doubling formula [ time-to-double = log(2) / log(1 + r) ] with a 7% annual interest rate gets you to 10.25 years. As far as estimated rates of return go, 7% is pretty average in terms of investment planning. Nothing ridiculous there.

      The Wikipedia article on internal rate of return has some examples of how the rates of return on capital projects are calculated in terms of cash flow.

    18. Re: Wait! by Calydor · · Score: 1

      After the election in 2016, and the following riots from anyone who disagreed with the election in 2016, do YOU want the average tax payer to be in charge of what top-tier researchers are actually researching?

      --
      -=This sig has nothing to do with my comment. Move along now=-
    19. Re:Wait! by Darinbob · · Score: 2

      You could perhaps spread research costs around to all projects. Such as in the olden days when major corporations had research arms out of which a few major advances and profit engines would arise as well as lots of smaller advances that would contribute much less to the bottom line. But then this really messes up costs for the commonly used drugs as well. This would make drugs for rarer drugs cheaper, but the drawback is that it makes the common drugs more expensive. The profits from Viagra are not paying for the malaria drugs.

      Ultimately you've got capitalism getting in the way of good medicine. The solution at the moment is to not sell to the patients directly, but to third parties. Such as insurance providers, the WHO, and non-profits. The marketing is to the doctors, who usually don't see the costs ($10/pill to do the job versus $1000/pill to do the job with less stomach upset, so that if you hide the price tag the doctor recommends the second one). The drawback to this solution is that it only encourages the pharma industry to continue the price gouging.

      I thinkt he solution may be bad PR. Even if this isn't fair, since the researchers aren't in the business to become rich, it sends a signal that people are watching.

    20. Re:Wait! by Applehu+Akbar · · Score: 1

      There is nothing much we can do about the new, branded medications in this list other than wait for the patent to expire, but compounds like Daraprim, the one Martin Shkreli wants $750 per pill for, are off patent and sell for pennies on the world market. If Trump wants to be taken seriously on this whole populism thing, it's time to strip the FDA of its power to prevent us from freely importing these long-since-approved ompounds.

    21. Re: Wait! by fluffernutter · · Score: 1

      So stop spending money on drug companies! Don't you do capitalism and talk with the invisible hand and all?

      --
      Laws are rules for the court, but merely a bottom bar to hit for life. Think beyond laws in your actions always.
    22. Re:Wait! by myowntrueself · · Score: 1

      If 3 million people is enough to consider that Hillary 'really won' the election then is 30 million people enough to consider these diseases worth fighting?

      That's 25-30 million people with 7,000 different diseases. That's about 4k people per disease. They're not researching a single cure for all those 30 million people.

      WTF does this have to do with the election or number of votes cast? There's only one person still obsessed with the election results and TFA isn't about him.

      Yeah I guess we can characterize individual presidential candidates as diseases... But whats the cure for Hillary or Trumpitis?

      --
      In the free world the media isn't government run; the government is media run.
    23. Re: Wait! by chihowa · · Score: 1

      I understand your frustration, but if you were in any way qualified to pick what they work on, you'd likely be working on it yourself.

      There's a pretty big gap between understanding a disease and knowing how to design a drug to treat it and being able to say, "Mah ass hurts, there otta be a cure for that!"

      --
      If you want a vision of the future, imagine a youtube comments section scrolling - forever.
    24. Re:Wait! by Interfacer · · Score: 3, Interesting

      Quite late in the discussion, but yes. I work as a sysadmin in a big biotech pharma company where we make special treatments for a specific rare disease that will kill the people who have it if they don't get it. It cannot be cured, because it is due to a genetic defect. The only option is to supply the patient with enzymes that their own body doesn't make.

      The medicine itself is 'reasonably' easy to make. But not when you have to comply with the regulatory requirements of various countries.

      All research, marketing and other costs aside, we have a half a billion dollar plant, with over 500 employees, to make a drug for only 2500 patients worldwide, give or take. You can do the math on that. The reason we need that many employees is because the rules surrounding biotech drugs is incredibly strict. We are audited several times per year by various agencies, and things like change control, exception and deviation management, etc, are gruesome. Top heavy and very labor intensive.

    25. Re: Wait! by Anonymous Coward · · Score: 1

      Million and billion are not the same.

    26. Re: Wait! by Kjella · · Score: 2

      Though I read somewhere that 90% of these (and other) drugs are made in the US, and then sold elsewhere as an afterthought to drive additional revenue. So in other words, European health care systems get a (mostly) free ride.

      Sure, they're just giving a first-world market more than twice the size of the US a free ride. Reality is that they don't make that much money in Europe because we don't let them. It's my impression that in the US the doctors do pretty much as they please, if it's "in" to use a certain brand of medicine they just do. The insurance companies aren't going to tell them you could have saved $100 here and $200 there by using cheaper generics, the hospital would just tell the bean counters to stick to what they know.

      Part of the universal healthcare is a lot more central direction of the medical side and purchasing. They're looking across the whole public health system, could we save money here using generics? And those recommendations get rolled out to hospitals, doctors and pharmacies. The brand drugs are always available for people that suffer side effects or don't get the intended effect from the generics, but basically you have to justify it. That means affecting doctors don't do you much good, they'll prescribe the cheap stuff first and the expensive stuff only when it's needed.

      And in public healthcare, the sky is not the limit. In the US you have a lot of people who can't pay very much and a few that can pay a lot. Here either we pay for it or we don't, but if we do it's for everyone so there's has to be a reasonable cost/effect. Sure, we have a few that could afford to pay the most expensive drugs and private doctors in the world but the money is in selling to the public system. There's just not a big enough market outside it to really make money that matters. And they will say no if the cost is excessive compared to the results.

      --
      Live today, because you never know what tomorrow brings
    27. Re: Wait! by lazylion · · Score: 1

      Then what would be the incentive to discover them in the first place?

    28. Re:Wait! by sjames · · Score: 1

      At $300,000/year if there are only 1000 people in the world with MD buying the drug, that's 300 million a year or about 6 billion over the life of the patent. Surely that will cover it all and a lot more.

      And unfortunately there's a LOT more than 1000 people with MD.

    29. Re: Wait! by ArmoredDragon · · Score: 1

      You have just described why Americans spend so much on healthcare and get so little compared to countries with "socialized" medical systems. The process applies to more than just drugs for comparatively rare diseases.

      Likely, yes.

    30. Re: Wait! by ArmoredDragon · · Score: 1

      After the election in 2016, and the following riots from anyone who disagreed with the election in 2016, do YOU want the average tax payer to be in charge of what top-tier researchers are actually researching?

      That's actually a really solid point. I felt a little embarrassed for the example our country set when electing Trump, but I felt even more embarrassed at the example our country set when masses of people...well...let's just put it like it is: protested democracy.

    31. Re: Wait! by SNRatio · · Score: 1

      The various drug companies spend 3 1/2 x as much on advertising and marketing as research, with MOST basic research paid for by governments and sold for pennies or given away for free Welfare starts at the top

      As a percentage of revenue Pharma spends more on R&D than almost any other industry.

    32. Re:Wait! by SNRatio · · Score: 1

      While I think these are likely a rip-off, you do also need to consider R&D costs and for rarer disorders the cost spread over a smaller number of dosages.

      Actually you don't. The price is set by finding the maximum value for (price per dose) x (doses sold per month). R&D is a sunk cost at that point. All else being equal, it doesn't matter whether they spent $100M or $10B, the price will still be the same.

    33. Re: Wait! by AutodidactLabrat · · Score: 1

      And?
      Given that they spend far more on Marketing, their claim "must have higher revenue" is specious

    34. Re:Wait! by martinfb · · Score: 1

      It's not the cost to mfgr the drug, it is the research and approval expenses that are expensive.

      The more rare the disease, the fewer sales, the higher the cost needs to be to justify research in the first place.

      That is, in many cases.
      However, drug companies tend to abuse this model to reap unreasonable profits in many areas.
      For example, the drug known as Harvoni, used to treat Hep C, a relatively non-rare affliction, costs ~$90,000 for a 8 week regimen!
      That's 56 pills @ ~$1607/pill! That works out to over $586K/yr (yet two 12 week courses is considered worst case needs).
      And there are lots of people with Hep C!

      And then there is the Epi-Pen debacle!
      Point is that drug companies definitely need to be reigned-in. Period.

      --


      Self-importance and self-indulgence is the root of ALL evil.
    35. Re: Wait! by Highdude702 · · Score: 1

      It costs a Fuck Ton of money to get a drug into testing trials....

    36. Re:Wait! by wisnoskij · · Score: 1

      Trillions of dollars are funneled into new drug research, so yes. spending billions to develop a drug that only a few hundred thousand will ever take (most of them receiving the drug for free because they are poor), is costly. Some drugs need to cost upwards of a million dollars per year just to make back the cost to produce said drugs.

      --
      Troll is not a replacement for I disagree.
    37. Re:Wait! by war4peace · · Score: 1

      Question is... how FAST is the ROI expected?
      There's a difference between ROI in 2 years and ROI in 10.

      --
      ...gis sdrawkcab (usually not responding to ACs; don't bother posting as AC)
    38. Re:Wait! by wisnoskij · · Score: 1

      I expect most ROI for drugs is best calculated over the drugs expected lifetime, if only because their lifetime is not likely to be very long for many drugs. They will be able to guess in broad strokes how long before a new improved drug comes out and makes this drug completely worthless.

      I am sure their are cancer fields where new drugs are expected to last 6 months before they are replaced with something new.

      --
      Troll is not a replacement for I disagree.
    39. Re: Wait! by ebvwfbw · · Score: 1

      After the election in 2016, and the following riots from anyone who disagreed with the election in 2016, do YOU want the average tax payer to be in charge of what top-tier researchers are actually researching?

      That's actually a really solid point. I felt a little embarrassed for the example our country set when electing Trump, but I felt even more embarrassed at the example our country set when masses of people...well...let's just put it like it is: protested democracy.

      You still don't get it. Let me paint a picture for you. 50+ years ago we had masked people, kids, even little kids running around in white outfits with a KKKK sign on them. We know they were democrats. Look them up, Governor Wallace, Senator Byrd, who Hillary even kissed.. and so on. All racists, bigots, fascist, communists, socialist... Leftists. All they did was change from a white outfit to a black one. Same racists, same leftists, same people trying to destroy America. The left loves to take what they call useful idiots to do their work. They did it with the white outfit, they did it with the black outfits. A lot if not all of them were paid as well.

      Trump wasn't my favorite either. However he is what we have because the left made him the candidate so Hillary was a sure bet, and she couldn't even beat him. Too many women, hispanics, everyone saw through her and her bullshit. Look at her logo, the twin towers with a plane flying through them.

      Trump is turning out to be a good one, looks like he's rebooting. He has a lot to learn though I don't think he'll ever be a real politician. They say he's a liar, though he's nothing like main stream media and the other politicians. The last POTUS would lie and it was so second nature it was really hard to tell. Let's hope we have a world left in 4 years. Don't let that bother you. I used to think that back in the 1970s, 1980s as well. Especially 1985.

    40. Re: Wait! by AutodidactLabrat · · Score: 1

      So....live with the theft of ANOTHER election without comment?
      THAT would be an unpardonable crime!

    41. Re: Wait! by AutodidactLabrat · · Score: 1

      "Turning out to be a Good One"?
      What is the color of your sky? It surely isn't blue

    42. Re: Wait! by ebvwfbw · · Score: 1

      "Turning out to be a Good One"?
      What is the color of your sky? It surely isn't blue

      It'll look that way to you soon enough. As soon as you come out of the stockholm syndrome.

  2. It's likely the PRICE, not the cost by haruchai · · Score: 2

    Just how many Martin Shkrelis are there in the (supposedly) (legal) drug business?

    --
    Pain is merely failure leaving the body
    1. Re:It's likely the PRICE, not the cost by MightyMartian · · Score: 3, Interesting

      Plenty. It's because we allow sociopaths to run companies. Sociopaths should be banned from all management positions, should be outlawed under pain of horrible death from having any power over any finances. They should be permitted, under heavy surveillance, to work flipping burgers at McDonalds or cleaning streets, but they should never ever be put in a position where they can affect a market or a pension fund or any significant transaction, and if they're caught trying to fuck around with their coworkers, they should be removed permanently from society.

      --
      The world's burning. Moped Jesus spotted on I50. Details at 11.
    2. Re:It's likely the PRICE, not the cost by geek · · Score: 4, Insightful

      You sound like a sociopath

    3. Re:It's likely the PRICE, not the cost by epyT-R · · Score: 3, Insightful

      ..and who decides who's a sociopath? The Local People's Social Justice Friendship House, which of course has absolutely no ideological bias against private business? I'll pass. It's just replacing one form of tyranny with another.

      There might be other solutions that could help. For example, if it is true that those companies are squandering large percentages of money on things like advertising, perhaps only allowing it to be funded from a set percentage of profits from sold product would be enough. This would hopefully limit the waste of research money on irrelevancies. While still not perfect, this is better than the witchhunt you suggested. Those never end well.

    4. Re:It's likely the PRICE, not the cost by WrongMonkey · · Score: 3, Funny

      ..and who decides who's a sociopath?

      Maybe a pharma company could develop some sort of test.

    5. Re:It's likely the PRICE, not the cost by pj2541 · · Score: 1

      ..and who decides who's a sociopath?

      Pretty easy, they run for office.

    6. Re:It's likely the PRICE, not the cost by Anonymous Coward · · Score: 1

      The problem is, how do you enforce it? Things like the Stanford Prison experiment show that even rational actors become irrational eventually. You have to limit the time enforcers in government office and police can serve.

      The other problem is sociopaths tends to be good at running business...

    7. Re:It's likely the PRICE, not the cost by haruchai · · Score: 1

      "You have to limit the time enforcers in government office and police can serve"
      So term limits for everyone? I'm ok with that. Especially if that includes sheriffs & judges

      --
      Pain is merely failure leaving the body
  3. The question to ask... by bogaboga · · Score: 1

    The average drug approved under the Orphan Drug Act of 1983 (ODA), which governs rare disease approval, costs $118,820 per year. Assuming a similar cost, if a single drug were approved under the ODA for 10% of rare diseases, the total would exceed $350 billion annually

    In this chain of healthcare, who is making the money?

    To be more precise, who is making a killing?

    It's a fact that some entity (cabal) is making big cash, but find it hard to come to terms that this cabal or cabals are profiteering over the misery of others in these United States.

    1. Re:The question to ask... by chispito · · Score: 1

      In this chain of healthcare, who is making the money?

      To be more precise, who is making a killing?

      It's a fact that some entity (cabal) is making big cash, but find it hard to come to terms that this cabal or cabals are profiteering over the misery of others in these United States.

      Without the profiteering, many of the drugs would not exist. It is difficult to conceive of a different model that maintains the current level of R&D.

      --
      The Daddy casts sleep on the Baby. The Baby resists!
    2. Re:The question to ask... by bluefoxlucid · · Score: 1

      The researchers in lab coats are making big money. A lot of it is their wages. The wages of people at chem synth companies, mining facilities, and other supply chain services is also a big part of the majority cost.

  4. value of human life by Anonymous Coward · · Score: 3, Insightful

    We have a culture built around the concept that human life is worth any amount of money. At the end of our lives we spend and spend to pry out another 2 weeks of lifespan.

    Instead maybe we should realize that with 7.5 billions of people, the value of any given human life is very close to zero. It sounds harsh, but it is also the truth. If people want to pay to save themselves, great have a go, but we should not be foisting that cost onto society when there is no rational reason. Spending those sums is absurd.

    We don't even treat our pets in that way: we realize that life is finite, and we try to keep them comfortable at the end so they do not suffer, but we are willing to acknowledge that there is a time when it is best to let them go. Ease their passing so they can go in peace and as much comfort as possible. We need to adopt this attitude for people as well.

    We're not a scattered band of 10K hunter-gatherers on the brink of extinction any longer. A random human life is simply not valuable.

    1. Re:value of human life by sinij · · Score: 1

      Old people vote, so good luck advocating common sense that 2 weeks of lifespan is not worth couple mil of other people's money.

    2. Re:value of human life by wildfish · · Score: 1

      Old people are not the problem. People with long term health issues that need to be managed are. That they want the best treatment is sort of a given. Most people I know in last year of life are dropping lots of drugs because long term health issues are no longer relevant.

    3. Re:value of human life by Altrag · · Score: 5, Insightful

      That's just not true. We value human lives very little. What we value is the lives of our friends and families.

      If your brother gets shot in Iraq, its a tragedy to you personally. If an Iraqi's brother gets shot, its a statistic to you. And the Iraqi thinks the exact same thing except in reverse.

      This is a good part of why Americans are so resistant to a decent healthcare system.. Joe is happy to spout off things like "well I'm not sick and nobody I know is sick so why should I be paying for Jane from 6 miles down the road?" But of course if Joe gets sick himself a year later, suddenly he's bitching about the cost of doctors and medicine. Because now it actually matters to him personally. His life is worth paying for but Jane's isn't. And Jane thinks the same way about Joe.

      Basically it all comes down to that "Monkeysphere" concept we hear about, combined with "greed solves everything" capitalism and some American-dream style eternal (if unfulfilled) optimism about a person's own potential.

    4. Re: value of human life by fropenn · · Score: 1

      How much do you value your own life? I pay for, you pay for me. That's how society worked.

    5. Re:value of human life by Altrag · · Score: 1

      Innovation is also slowing as established corporations play the regulation games.

      Yes, the damned government trying to prevent another Thalidomide disaster. It should be up to each customer to do all of the research and clinical trials needed to prove a drug safe for themselves! I mean that's a thing any random dummy on the street should be able to to do right? The US only avoided the Thalidomide disaster because the government saw what was happening in other countries and told the corporations "hell no!"

      The US actually has an excellent health care system, it just happens to be one that many can't afford

      You should have ended the sentence there. Somebody has to pay for the clinical trials and other hoops that new drugs have to go through, and if its not the manufacturer then its you. And not always with money. How many people "paid" for Thalidomide with their childrens' life?

      then it will have a healthcare system that serves all, poorly

      I personally prefer a healthcare system that can help 90% of everyone's problems than one that can help 99% of the 1% and just lets everyone else suffer and die. Especially since I'm nowhere close to the 1%.

  5. Nonsense by c · · Score: 5, Insightful

    What's threatening the US health care system is putting profit ahead of lives.

    Good luck. You poor saps are going to need a lot of it.

    --
    Log in or piss off.
    1. Re:Nonsense by blindseer · · Score: 3, Interesting

      If there is no profit in saving lives then it cannot go on for long. If drug companies cannot profit making drugs then their won't be any drug companies. If a brain surgeon gets paid as much as a truck driver then you aren't going to have many brain surgeons, at least not many that's any better trained than a typical truck driver.

      This is not a choice between lives and profit, we can have both.

      What a lot of nations chose to do is, out of "compassion", put government in charge of providing medical care. This has been and will always become a disaster. The people that provide care may be the best people at the start but without competition, which requires a profit motive, the quality of care will fade. People need motivation to improve, provide quality care, and profit provides that.

      It sucks that labor and materials cost money but that is the world we live in and that cannot be changed. Removing the profit motive to providing quality medical care and people WILL die needlessly.

      Even the most compassionate person needs resources to provide medical care to those in need. The best, and perhaps only, means to make sure that the compassionate have those resources is with a free market. A free market means people will profit.

      --
      I am armed because I am free. I am free because I am armed.
    2. Re:Nonsense by rhazz · · Score: 1

      What a lot of nations chose to do is, out of "compassion", put government in charge of providing medical care. This has been and will always become a disaster.

      Are you calling universal healthcare a disaster?

    3. Re:Nonsense by Areyoukiddingme · · Score: 3, Insightful

      The problem is not that we put profit ahead of lives but rather that we haven't fixed health care so it properly comes under traditional market forces.

      When are you braindead idiots going to get it? When the choice is pay or die, there is no market! Goddamnit, how stupid can you possibly be? Markets require choice. Healthcare is not optional. End of discussion. Healthcare can not be managed via a market.

      If you've fallen off your roof and broken your leg and nicked your femoral artery, do you:

      a) Methodically call up each of the six independent healthcare providers in your area and ask them for their up-front pricing for repairing your artery and setting your broken leg, then carefully research their quality of care online, paying appropriate attention to their average outcomes specifically for treating a broken leg before calling back your provider of choice and making a reservation for them to come and get you; or

      b) Dial 911, frantically convey your situation, and pray the EMTs get to you before you bleed the fuck out?

      I'm gonna guess option b). And if in some fever dream, you really think you'd pursue option a), I hope you fall off your fucking roof.

      God DAMN I'm sick of you anonymous, cowardly fucks. You know your psychopathic ideas are wrong, or you'd post with an account and accept the downmods you deserve.

    4. Re:Nonsense by blindseer · · Score: 1

      Abso-fucking-lutely.

      --
      I am armed because I am free. I am free because I am armed.
    5. Re:Nonsense by c · · Score: 1

      This is not a choice between lives and profit, we can have both.

      Sure. Really, I honestly do wish you folks the best of luck with your great Hobbesian experiment... and please don't export it to the rest of the world.

      --
      Log in or piss off.
    6. Re:Nonsense by blindseer · · Score: 2

      It is coming to the rest of the world, one way or another.

      I've been hearing about the nightmares of healthcare in Canada and the UK. One thing was a Canada court ruling that denying people the ability to seek medical care on the private market was a human rights violation. This opened the gates to what Canadians call "super hospitals" but we in the USA call "hospitals". Canada had made it illegal for people to buy private insurance or seek care from private care providers. This caused the government run system to become overwhelmed. Canadians were fleeing to the USA for care, including prominent government officials.

      In the UK a large portion of the population have private medical insurance because of the poor care from the government. Britons are (or at least were) dying of thirst and hunger in their beds because the care providers were not properly trained and/or simply did not care.

      I've been receiving government funded healthcare in the USA from the Veterans Administration for over a decade now. Until a year or so ago if I wanted to see a physician it could take weeks. Once in a time of excruciating pain I called a local hospital, I got an appointment within the hour, was treated well, and at a cost I could pay out of pocket. Maybe I could have called the VA and tried to get them to pay my bill since it was related to my injury from military service but I didn't, I felt better and that was what mattered. The VA hospitals have improved lately, because some high profile deaths and suicides forced some oversight. Now I can get to see a care provider in days, better but still not great, and not near what I got from a private provider.

      Across the world the best indicator for the survival of a person afflicted with a life threatening condition is if one is living in the USA. You can claim that medical care in the USA is somehow "wrong" but it's the best in the world. I don't want to see that messed with. I want to see it improve and, out of compassion for others, I wish other nations would follow our lead.

      Canada, UK, and other nations are starting to realize that their medical care sucks. I assume a lot of this has to do with people leaving for the USA for care, and the greater ease of communication and travel from modern technology enabling more people to do this. So, you will see more people getting American style health care, either by them coming here or the system of care spreading to other nations.

      --
      I am armed because I am free. I am free because I am armed.
    7. Re:Nonsense by naubol · · Score: 1

      I'm concerned you don't have a mental health policy in your plan.

      Certainly, it's challenging to expose market forces because of situations like you described -- a point I admitted in the post you're responding to. Other than you basically explaining one of the reasons why it is difficult to bring market forces to bear on health care, the point I made, you don't seem to have responded to my post or understood that I am for universal health care despite stating it explicitly.

      Also, I was posting from work. I'm sure it's common to post anonymously from work.

      --
      Reality is a slackware box running on a 386 tucked away in god's sock drawer.
    8. Re: Nonsense by blindseer · · Score: 1

      Tell me....what exactly is a "food stamp"?

      We don't have food stamps any more. We have SNAP (Supplemental Nutrition Assistance Program, commonly called EBT because payments are done by electronic banking transactions), which is a welfare system a lot like your Centrelink.

      Remarkable....only in the US huh ?

      Right, because poverty is a uniquely American problem.

      She was in tears when she found out in Australia her father would have received excellent medical care without draining his whole fortune to nothing once the insurance ran out.

      Tell me something, what are the taxes like in Australia? I can look it up. It appears that on the average Americans lose 25% of their income to taxes while Australians lose 45%. Interesting. You think this "excellent" health care doesn't come at a cost? That socialized health care you get is prepaid health care, you are paying for it whether you use it or not. You pay for it if you like it or not. It's not free, because nothing is free.

      What you point out is one of the huge problems with what we call "Obamacare", it ties medical insurance with employment. The reason your friend had to see her father lose his fortune paying for medical care is because of a long series of events that created an incentive for employers to provide medical insurance. My dad was a farmer, worked his own land and therefore he was his employer. He set aside some of his income to buy top notch medical insurance. When he got cancer he had his choice of hospitals to go to for surgery. He could have gone to one of the best hospitals in the world, and had it all paid for. He chose to get his care at the local hospital, which was only a half hour drive from his home, because he didn't want to be far from family. He got a highly qualified surgeon, and the best medicines available. All in a small Midwestern town.

      In America we have choices. We can choose our care, and that means one can choose poorly. That VP of Engineering took a gamble on the kind of insurance he got and lost. That's unfortunate. It does not erase things like the excellent cancer survival rates in the USA.

      --
      I am armed because I am free. I am free because I am armed.
  6. No LIMITS by JimSadler · · Score: 2

    Our society is so corrupt that we do not regulate the costs or profits made by drug producers. There are drugs that are dirt cheap to produce that cost a king's ransom. I suppose that the right wing will consider that as a freedom issue which is nonsense. Do they mean free to die in agony?

    1. Re:No LIMITS by wiggles · · Score: 1

      See, here's the issue.

      NHS and other non-US markets negotiate prices with drug companies, often forcing them to sell those medications at a loss or lose access entirely to that market. In order to make that loss back, they have to shift the cost of the drug to markets who do not force pricing - especially the USA. That's one big reason why the US has jacked up prices - we are effectively subsidizing medical treatments for the rest of the world.

      When you implement price controls and force a producer to sell something at a loss, they have to jack up the price elsewhere, or else go out of business. TANSTAAFL.

    2. Re:No LIMITS by OrangeTide · · Score: 1

      That's precisely their argument. They'll tell you that if you don't like the price of drugs, you should refuse to buy them and let the free market decide. There are always [technically] alternatives, because the was a time before the new drugs existed. But the old treatment may have been to lay in bed doped up on morphine while you wait to die.

      --
      “Common sense is not so common.” — Voltaire
  7. Re:Stupid summary is STUPID by avandesande · · Score: 3, Interesting

    It's not a free market. By law, US consumers cannot import drugs from other countries. The $50,000+ dollars for hepatitis drug is under a thousand in India.

    --
    love is just extroverted narcissism
  8. Not just "rare" diseases by PopeRatzo · · Score: 5, Informative

    The cost of Sovaldi and Daklinza (used together) to treat Hepatitis C (which infects 3.5-5 million Americans), is $336,000 for the 24-week course of treatment. $1000 for each pill. The cure rate of Sovaldi and Daklinza is approximately 90%. The same drugs in India cost about $4 per pill.

    Hepatitis C currently kills more Americans than any other infectious disease.

    https://www.cdc.gov/media/rele...

     

    --
    You are welcome on my lawn.
    1. Re:Not just "rare" diseases by Gilgaron · · Score: 1

      Do you know if India is producing the drug legitimately or is it violating intellectual property laws? If the former then... wow... it is like DVD region control taken to the extreme...

    2. Re:Not just "rare" diseases by Baron_Yam · · Score: 1

      Well, I've never wanted to travel to India, but a nice long vacation there seems like a no-brainer if you get Hep-C and aren't extremely wealthy.

        I could just do a quick round trip to get the drugs and not even worry about missing work or having to pay for a hotel room.

      Customs would probably steal the drugs from me at the border, I suppose, and maybe lock me up as a mule.

    3. Re:Not just "rare" diseases by Anonymous Coward · · Score: 1

      It is doing it 100% legitimately. You know why? Because in India, medications can't be patented. The public policy reason behind this is that their society sees attempting to keep 1 billion people reasonably healthy as a more worthy endeavor than lining the pockets of unscrupulous pharma execs.

    4. Re:Not just "rare" diseases by fustakrakich · · Score: 1

      Sounds like flying to India for a refill is the way to go.

      --
      “He’s not deformed, he’s just drunk!”
    5. Re:Not just "rare" diseases by PopeRatzo · · Score: 1

      Sounds like flying to India for a refill is the way to go.

      India has started limiting access to these drugs to Indian citizens.

      --
      You are welcome on my lawn.
    6. Re:Not just "rare" diseases by PopeRatzo · · Score: 1

      Well, I've never wanted to travel to India, but a nice long vacation there seems like a no-brainer if you get Hep-C and aren't extremely wealthy.

      Unfortunately, that doesn't work any more. India has placed limits on pharmaceutical tourism. They're probably worried about Big Pharma launching a Tomahawk missile strike on them or something.

      --
      You are welcome on my lawn.
    7. Re:Not just "rare" diseases by chispito · · Score: 1

      Because in India, medications can't be patented. The public policy reason behind this is that their society sees attempting to keep 1 billion people reasonably healthy as a more worthy endeavor than lining the pockets of unscrupulous pharma execs.

      Well, that right there is probably why all the funding that went into developing them went to New Jersey and not New Delhi. The US healthcare system is subsidizing the drugs for India.

      --
      The Daddy casts sleep on the Baby. The Baby resists!
    8. Re:Not just "rare" diseases by chispito · · Score: 2

      The cost of Sovaldi and Daklinza (used together) to treat Hepatitis C (which infects 3.5-5 million Americans), is $336,000 for the 24-week course of treatment. $1000 for each pill. The cure rate of Sovaldi and Daklinza is approximately 90%. The same drugs in India cost about $4 per pill.

      Honest question: If the US had the same laws as India, would the drugs exist? If everything were government funded or if wild success did not necessarily mean wild profits, do you think we'd get the same quality results?

      Both drugs were developed in New Jersey.

      --
      The Daddy casts sleep on the Baby. The Baby resists!
    9. Re:Not just "rare" diseases by fustakrakich · · Score: 1

      What, there's a shortage?

      --
      “He’s not deformed, he’s just drunk!”
    10. Re:Not just "rare" diseases by PopeRatzo · · Score: 1

      Honest question: If the US had the same laws as India, would the drugs exist? I

      A better question might be, "If the drugs were developed in New Jersey, then why does a smaller percentage of Hepatitis C patients in the US have access to them than Hepatitis C patients in India?"

      --
      You are welcome on my lawn.
    11. Re:Not just "rare" diseases by pnutjam · · Score: 2

      They would, we're just used to hearing Big Pharma's side of the argument.
      citation: http://www.huffingtonpost.com/...

    12. Re:Not just "rare" diseases by Headw1nd · · Score: 1

      With $996 potential profit per pill and a GDP of $1,500 per capita I can't imagine that is going to work all that well.

    13. Re:Not just "rare" diseases by Baron_Yam · · Score: 1

      It's OK, I have a fallback plan... I just continue to live in Canada.

    14. Re:Not just "rare" diseases by argStyopa · · Score: 2

      And what would India have to pay if the US consumers weren't subsidizing that price?

      Fundamentally, the Western (and increasingly the rest of the world) has a problem with medicine: we are capable of amazing feats of medicine and healing. At what point do we have the courage to start deciding what human lives are worth?

      1) Yes, we can save that hemophilic fatally allergic-to-everything crack child. It'll only cost $300,000 a year in constant hospitalization, therapy, and treatments. And if we're lucky, they'll live to 12. Is her 12 years of life worth $3.6 million?
      2) Or that 84 year old can get a new heart, new lungs, new kidneys, live in permacare at $10k/mo...are the 6 years of life he'll (maybe) get worth $3.6 million?
      3) Meanwhile, kids are starving in orphanages in Guatemala where $10 will feed the kid for a year, and $20 will give them basic medical care. Are person

      Are 1) and 2) each worth 120,000 3)'s? Really?

      --
      -Styopa
    15. Re:Not just "rare" diseases by rhazz · · Score: 4, Informative
      The drug is licensed to drug manufacturers in India who produce it and sell it. The difference is that the Indian government negotiates an acceptable price range for the drug. Most western governments do the same price negotiation. The US does not, at all, by law. Source

      However, in the United States, price negotiation for medicine doesn’t exist. Medicare is required to accept the price given by the pharmaceutical company. Federal law doesn’t even allow Medicare to bargain or negotiate bulk discounts. It is only logical that under these circumstances the prices skyrocket, and it becomes the norm to pay high prices for medication.

    16. Re:Not just "rare" diseases by rhazz · · Score: 1

      The drug is licensed to Indian manufacturers at low prices (due to government negotiation). If India's drug tourism industry takes too big a bite out of other markets that the pharma company is gouging, that company might end those licensing agreements leaving India without (legal) access to the drug.

    17. Re:Not just "rare" diseases by PopeRatzo · · Score: 1

      2) Or that 84 year old can get a new heart, new lungs, new kidneys, live in permacare at $10k/mo...are the 6 years of life he'll (maybe) get worth $3.6 million?

      False argument. 84 year olds don't get heart transplants.

      I think the question you want to ask is, "Should we only give expensive treatments to the richest people in society?"

      At what point do we have the courage to start deciding what human lives are worth?

      That question doesn't represent courage. It represents cowardice.

      The United States just spent over $80,000,000.00 to sent 60 Tomahawk missiles to destroy zero active aircraft. Six planes that were grounded for repairs were reportedly destroyed. How many Guatemalan orphans would that feed?

      --
      You are welcome on my lawn.
    18. Re:Not just "rare" diseases by SirKveldulv · · Score: 1

      Drug companies aren't under any obligation to supply India, or anyone else for that matter. What sort of insanity makes you believe they're doing it out of the goodness of their hearts ? The drug companies and US healthcare system are price gouging and ripping you off, simple as that.

    19. Re:Not just "rare" diseases by argStyopa · · Score: 1

      Oh stop.
      First, this isn't a guns vs butter argument. You can just quit flogging your particular SJW cause of "we spend too much on defense and not enough on medicine" if you want to be taken seriously.

      Second, re 84-year old heart transplant: miss the point much? OK "70 year old heart transplant" - better? Maybe you can stop being distracted by trivia? (https://www.ncbi.nlm.nih.gov/pubmed/22172859) The point being: medical care is very much a 80/20 thing: there's a HUGE amount of money spent on the last years of life (Forbes claims 50% of health $ spent for the last 5% of life) - is that the best use of medical resources?

      Third, so you don't like 'wealth' being the determining factor. Considering that medical resources are finite, what is the better solution to who gets the best health care treatments? Lottery? Nepotism? Meritocratic yardstick? Some bureaucrat's decision? Or do we ban advanced medical treatments completely, since we can't afford to give them to everyone? I'm genuinely curious how you would allocate such resources.

      --
      -Styopa
    20. Re:Not just "rare" diseases by PopeRatzo · · Score: 1

      First, this isn't a guns vs butter argument. You can just quit flogging your particular SJW cause of "we spend too much on defense and not enough on medicine" if you want to be taken seriously.

      This is what you said:

      3) Meanwhile, kids are starving in orphanages in Guatemala where $10 will feed the kid for a year, and $20 will give them basic medical care.

      You're the one who sounds like an SJW.

      Second, re 84-year old heart transplant: miss the point much? OK "70 year old heart transplant" - better?

      No, jackoff, it's not better. There is a very small number of people over 70 who get heart transplants. Just a few hundred. Don't you remember what a big deal it was when the 70-something Dick Cheney got his (first) heart transplant? It was almost unheard-of. And by the way, when you're 70, I'll ask you again if the difference between you and an 84 year old is just "trivia".

      Third, so you don't like 'wealth' being the determining factor. Considering that medical resources are finite, what is the better solution to who gets the best health care treatments? Lottery? Nepotism? Meritocratic yardstick? Some bureaucrat's decision? Or do we ban advanced medical treatments completely, since we can't afford to give them to everyone? I'm genuinely curious how you would allocate such resources.

      Gee, if only there were other developed countries who had already figured this thing out...

      You know, honestly, you can take your neoliberal, Ayn Rand bullshit and stick it up your ass. It's never, ever worked anywhere in the world. At least not anywhere you'd want to be. You're living in a Republican college freshman fantasy.

      --
      You are welcome on my lawn.
    21. Re:Not just "rare" diseases by argStyopa · · Score: 1

      You entirely miss the point, repeatedly.
      1) you made it guns vs butter. It's not. It's butter vs butter.
      2) regardless of the quantity of care, the point is the spending massive piles of $ on a few people to extend their lives a small amount, vs small amounts that would materially improve the lives of many. That's not "SJW" that's an actual question we as a society fail to face.
      3) regarding alternatives to wealth being the determining factor: so you really HAVE no answer. Check. Can't comprehend capitalism: check.

      Crabby, whingy bitch: check.

      --
      -Styopa
    22. Re:Not just "rare" diseases by PopeRatzo · · Score: 1

      regarding alternatives to wealth being the determining factor: so you really HAVE no answer. Check. Can't comprehend capitalism: check.

      Practically every civilized country in the world besides the US has figured out an alternative to wealth being the determining factor, and they spend much less to get better outcomes.

      Can't comprehend capitalism: check.

      You don't seem to grasp the fundamentals of late-stage capitalism. It's stage 4 and it's terminal.

      --
      You are welcome on my lawn.
  9. The US subsidizes healthcare for the rest of the w by DatbeDank · · Score: 4, Informative

    A little known secret: Most countries' governments arbitrarily set the price of drugs and medical devices during negotiations and force pharma and medical device manufactures to sell it at a loss (or simply not have access to that market). To make up for the R&D and marketing, they have to jack the price up in the US to make up the loss. http://www.ibtimes.com/how-us-...

    With the upcoming collapse of Obamacare, the rest of the world should be afraid of the US doing the same to the drug and med device companies. The cost of healthcare for the rest of the world will go up while it goes down for the US. I shudder to think about the hoards of angry folks when NHS starts becoming moderately expensive.

  10. The invisible hand of the free market by OrangeTide · · Score: 1

    Do you mean produce as in to manufacture. Or do you mean to research and development and manufacture? If it's a rare disease then it by definition doesn't achieve economies of scale.

    Some rare diseases, if untreated, will lead to a person's death. That's bad of course.
    Other rare diseases primarily impact quality of life and treatment can turn an sick unproductive person into a functional productive one. That's good for society, although you will probably have trouble justifying it by the numbers alone if you treat healthcare as an ROI problem. (return on investment)

     

    --
    “Common sense is not so common.” — Voltaire
    1. Re:The invisible hand of the free market by war4peace · · Score: 1

      I picked the train of logic AFTER the question of whether it makes sense to spend X billions of dollars on research for disease Y and save Z amount of people, where Z is under 1000 and the positive economic impact is near zero.

      R&D is tricky to measure, a study costing a million dollars can yield 10 billion dollars, while another study costing 500 million dollars might yield 5 million. therefore one R&D could cover another.

      Hell, a simpler solution would be to ever-so-slightly raise the price of common, cheaply available patented medication to support the insanely expensive, but rarely used ones. I'd happily pay 5 dollars on a 4.50 dollars med bottle if the 50 cents difference would cover a rare disease medication (paid for by me and 600,000 other people who bought that kind of med).

      --
      ...gis sdrawkcab (usually not responding to ACs; don't bother posting as AC)
    2. Re:The invisible hand of the free market by OrangeTide · · Score: 1

      Having some people pay more in order to support the needs of other people sounds like socialism.

      --
      “Common sense is not so common.” — Voltaire
    3. Re:The invisible hand of the free market by war4peace · · Score: 1

      I don't give a fuck what it sounds like.
      However, I care about how helpful it is.

      --
      ...gis sdrawkcab (usually not responding to ACs; don't bother posting as AC)
    4. Re:The invisible hand of the free market by currently_awake · · Score: 1

      You mean like having people pay for the police and military through taxes instead of user fees? Yes that is socialism.

    5. Re:The invisible hand of the free market by OrangeTide · · Score: 1

      Paved roads == tyranny!

      --
      “Common sense is not so common.” — Voltaire
  11. 75% Margins by Anonymous Coward · · Score: 5, Interesting

    Bristol-Meyers Squib has a 75% margin on their drugs. And almost 30% return on equity.

    They like to blame R&D but one Summer I worked at one of their research labs. It was a very very nice place. Parts could have been from a country club. The head of the place helicoptered in from NY every morning - which is all considered R&D "costs". The cafeteria food was 5-star but cost as much as a McDonald's meal.

    The only sucky part was the animal section.

    I miss that place.

    1. Re:75% Margins by bluefoxlucid · · Score: 1

      The question is: what fraction of the cost did that overhead reflect? I've seen gross-mismanagement, and I've seen stuff that's so damned expensive that a 0.5% extra expense is... a lot.

      Executive salaries are typically interesting in that respect: the actual cash compensation for most executives amounts to pennies per hour. The CEO of Ford gets, from revenue, about 1.05 cents per employee per hour, or $21 per year; stock and options compensation come at the expense of diluting stock--basically the business pays nothing, issues new stock, and investors in the secondary security market all wind up holding pink slips they can sell for slightly-less than they could yesterday. That means Ford basically robs a penny here and there from your 401(k) to pay its CEO, CFO, etc.

      People see executives with $20 million compensation and talk about how they should give that to their employees; then you find that their cash compensation (salary and bonuses) is only $7 million (most of which covers taxes on the other $13 million), and their 300,000 employees would each receive $23/year or a raise of 1.17 cents per hour.

      So are the R&D perks 40% of the budget or 0.4% of the budget?

    2. Re:75% Margins by blindseer · · Score: 1

      Then introduce competition. Bristol-Meyers can get away with paying for a helicopter ride very day because the FDA has created rules that makes getting into the drug business nearly impossible. Someone could bring this all to a screeching halt by bringing in a competitor that offers products for less because they aren't paying for aviation fuel and a helicopter pilot.

      --
      I am armed because I am free. I am free because I am armed.
    3. Re:75% Margins by blindseer · · Score: 1

      Of course, because properly testing medications means the facility manager must arrive on a helicopter daily.

      --
      I am armed because I am free. I am free because I am armed.
    4. Re:75% Margins by SNRatio · · Score: 1

      Bristol-Meyers Squib has a 75% margin on their drugs. And almost 30% return on equity.

      They like to blame R&D but one Summer I worked at one of their research labs. It was a very very nice place. Parts could have been from a country club. The head of the place helicoptered in from NY every morning - which is all considered R&D "costs". The cafeteria food was 5-star but cost as much as a McDonald's meal.

      The only sucky part was the animal section.

      I miss that place.

      Hate to break it to you but you are talking about the CHEAP end of R&D costs: preclinical. The vast majority of spending is in phase II and III clinical trials.

    5. Re: 75% Margins by Jesus+H+Rolle · · Score: 1
      Hate to break it to you but you are talking about the CHEAP end of R&D costs: preclinical. The vast majority of spending is in phase II and III clinical trials.

      In all seriousness, why are clinical trials so expensive? Volunteers, a doctor with a sack of pills, a lab technician and a statistician are all you need, no?

    6. Re: 75% Margins by SNRatio · · Score: 1

      In all seriousness, why are clinical trials so expensive? Volunteers, a doctor with a sack of pills, a lab technician and a statistician are all you need, no?

      In essence, but things get complicated pretty quickly. You don't have to pay the volunteers (though that happens frequently enough in phase I), but you do have to recruit them. A lot of them: phase III trials can have thousands of patients. That means lots of money to the medical practices that are treating people with that condition. Then you have to screen them to make certain that they fall into the groups you want to look at, which means lots of tests. a "sack of pills" can mean a weekly injection of a monoclonal antibody (which are still pretty expensive to manufacture) at a doctor's office. Monitoring during a trial can mean lots of tests, including CT scans and other imaging. And clinical trials can be looong. For things like cardiovascular conditions or Alzheimers you have to run them for years before the results start to show. Then there's the paperwork. If there's ever a situation where, yeah, it IS important to make certain everything was documented correctly, by the right people, and then stored in a secure manner, it's a clinical trial.

  12. "and there is no U.S. governmental equivalent of.. by Dupedupeshakur · · Score: 1

    NICE." It's true, there isn't - but insurers handle this in the private sector.

  13. Re:Attn Americans by amicusNYCL · · Score: 4, Interesting

    The problem is not that we aren't spending enough money. The problem is the combination of the pharmaceutical and insurance industries getting all of the money they can out of anything they have with no limits. Even generic drugs that aren't under patent production are many, many times more expensive in the US than in other countries (one example my wife gave me last night is $0.18 per pill abroad, versus $30 per pill here - for a generic medication). If the pharmaceutical companies are not actively engaged in collusion and price-fixing for generic medications then I would be shocked. Additionally, they spend so much money buying legislators that it is effectively impossible to get any legislation passed which would force a resolution to this issue by capping the price of medications or making it easier for additional companies to manufacture generic medications and compete with the established players. The free market is obviously not working correctly when every company making a certain generic medication sells it for the same amount, or when generic drugs which are readily available in other countries are not available here because they would compete with products from established companies. There is an opportunity there for a competitor to sell it for less and undercut the competition and make money, but for some reason that doesn't happen. If the free market is not allowed to work, and instead there is price gouging going on, then it sounds like legislation is required to correct that issue and bring drug prices down as a matter of law. If anyone thinks that such a thing would limit development or force companies out of business then I would invite those people to look at the P/L statements for the major pharmaceutical companies. A good start may be to outlaw advertising to consumers for pharmaceuticals, followed by a way to cap prices on medication based on metrics similar to those used by NICE.

    --
    "Our two-party system is like a bowl of shit looking at itself in a mirror." - Lewis Black
  14. I'm shocked the drug companies are so greedy by frovingslosh · · Score: 4, Insightful

    We all know these drugs have an insane markup. The drug companies are getting rick because they set astronomical prices for drugs the might help people, even a little. And they get it because insurance is forced to pay for it, not individuals who could never come up with the money on an individual basis. We have created the problem by mandating insurance and then letting the drug companies pilfer it blind.

    This is just another facet of the problem that drug companies use U.S. public funding for the research to help develop most of these drugs, then turn around and charge the American taxpayer more for the drugs than they sell them in other countries, both third world countries like the African nations and first world countries like Canada. And, of course, they spend a lot on expensive lobbying to buy politicians to make sure we in America don't get access to those drugs they sell in Canada.

    --
    I'm an American. I love this country and the freedoms that we used to have.
    1. Re:I'm shocked the drug companies are so greedy by eth1 · · Score: 1

      We all know these drugs have an insane markup. The drug companies are getting rick because they set astronomical prices for drugs the might help people, even a little. And they get it because insurance is forced to pay for it, not individuals who could never come up with the money on an individual basis. We have created the problem by mandating insurance and then letting the drug companies pilfer it blind.

      It's possible I just don't know how things work, but are the insurance companies really *forced* to pay those prices? Why can't they look at how much it costs to produce a drug and simply refuse to pay more than a certain price for it? Most people won't be able to afford it, and the drug company's market shrinks. The first insurance company to do this would have a competitive advantage, and I'd think the rest would have to follow suit. Meaning the drug companies sell cheaper or have little to no market. Obviously, they're not currently doing this, so there must be a reason...

  15. Re:Stupid summary is STUPID by amicusNYCL · · Score: 1

    Right, medical liberty. The freedom to either pay $300k per year for treatment, or die. Give me liberty and give me death, right?

    --
    "Our two-party system is like a bowl of shit looking at itself in a mirror." - Lewis Black
  16. The cost of drugs for rare diseases? by Lucas123 · · Score: 4, Insightful

    Common statin's (for lowering cholesterol) can cost more than $700 for a 30-day prescription if you don't have insurance. I think the cost issue goes well beyond prescription drugs for rare diseases, and in fact, is more detrimental in a broader sense.

    But, when we as citizens don't insist our politicians address campaign finance reform, policies favoring corporations will continue to guarantee price gouging will continue. Campaign finance reform should be made the top issue... Every. Single. Election.

    1. Re:The cost of drugs for rare diseases? by 31415926535897 · · Score: 1

      Doctors are complicit here. I've had three try to prescribe me meds for my borderline high cholesterol. I've been healthy in every other way except for that my whole adult life, so there seems to be some kind of genetic issue I have with cholesterol.

      Anyway, I saw the Harvard study that said that 2 oz of walnuts per day would lower bad cholesterol and raise good cholesterol. And you know what, after 6 weeks, IT DID. For the first time in my life I've had normal cholesterol.

      Why did my doctors not know about this study? Or even worse, if they did know about it, why didn't they encourage me to try it?

    2. Re:The cost of drugs for rare diseases? by strikethree · · Score: 1

      But, when we as citizens don't insist our politicians address campaign finance reform, policies favoring corporations will continue to guarantee price gouging will continue. Campaign finance reform should be made the top issue... Every. Single. Election.

      It is sweet that you think it is apathy from the public that is inhibiting campaign finance reform. It must be cozy inside that little world of yours. Come out and take a long look at the guns, blood, and enslavement that actually inhibits such changes. Enjoy. :)

      --
      "Someone needs to talk to the tree of liberty about its ghoulish drinking problem." by ohnocitizen
  17. Government Research Priorities to Blame by Roger+W+Moore · · Score: 1

    There is a far bigger systemic problem behind this than market gouging. Governments poor billions into medical research: the salary for medical researchers is 2-3 times that of scientific researchers and the government budgets for medical research far outpace those for science in many countries because it is politically easy to justify developing a new drug or a new treatment.

    This is the long term problem behind spiraling medical costs. Money spent on developing new medical treatments end up costing society more and more money. In the past these costs were offset by scientific advances which lead to improvements in productivity which generate money for society. The long term solution is to spend less money on developing new and more expensive treatments and spend more money on the fundamental sciences which will give us the ability to pay for them. However I see little chance of this happening because nobody wants to hear about cuts in medical research funding.

  18. No it won't by rsilvergun · · Score: 5, Insightful

    The industry doesn't do much research. Not the expensive kind. They do a few clinical trials after the government has done the really expensive stuff (what's called "Basic Research", IIRC).

    Also, what you're seeing here with these rare disease drugs is the style of capitalism popularized by Bane Capital: Find something undervalued and buy it up then extract the value for yourself. Usually this takes the form of liquidating the company. But in these cases they're selling life saving medicine. It's literally a matter of life or death (or a life worse than death). These are small markets with a high barrier to entry where the customers depend on the product to live. This is exactly the sort of thing no decent society would leave in the hands of unregulated capitalism. American on the other hand...

    --
    Hi! I make Firefox Plug-ins. Check 'em out @ https://addons.mozilla.org/en-US/firefox/addon/youtube-mp3-podcaster/
    1. Re:No it won't by the+gnat · · Score: 1

      They do a few clinical trials after the government has done the really expensive stuff (what's called "Basic Research", IIRC).

      This is simply wrong. The development process (which includes a lot more than just clinical trials) is far more expensive than the basic research component - and that's without even counting how many projects simply fail without anything to show for it.

    2. Re:No it won't by avandesande · · Score: 4, Informative

      The majority of drug makers spend more on marketing than R&D

      --
      love is just extroverted narcissism
    3. Re:No it won't by Insanity+Defense · · Score: 1

      The 2.5 billion is for a NEW drug. Many of these high priced drugs for rare diseases are out of patent drugs that are given a new patent which applies only when used to treat the rare disease. The drug development is over and done with.

    4. Re:No it won't by the+gnat · · Score: 1

      This is common knowledge to anyone who has worked in the field - it's like asking for a citation for the claim that eating too much junk food leads to obesity. But here are two data points:

      http://blogs.sciencemag.org/pi...
      https://en.wikipedia.org/wiki/...

      So that's less than 20% of approved drugs that are discovered in academia to begin with. Academic labs aren't large-scale operations - a single-investigator R01 grant from the NIH might be $5 million over 5 years, and most investigators won't have more than a handful of these. For the really big superstar labs, let's assume a very generous upper bounds of $10 million per year (not all of which is necessarily from the government). If it's a big multi-investigator project, maybe double that. Except for a handful of big centers (like the NIH itself, or genome sequencing centers), academia just doesn't operate at a large scale - a typical university research department is just an aggregation of many smaller units that are largely autonomous. The hidden advantage to these organizational limitations is that failed projects usually fail before anyone spends too much money on them. So let's hypothesize at the extreme, academics spent no more than $50 million per drug candidate. Compare to the numbers in the Wikipedia article.

      Now, you could of course argue that because drug development is informed by the public-domain knowledge generated by taxpayer-funded researchers, drug companies are leaching off the public in that way too. I guess that's technically true (albeit difficult-to-impossible to quantify), but you might as well argue that because the government invented digital computers, companies like IBM and Intel should have been nationalized. (Note that the difference in salary between academia and big pharma is relatively large - to shift more drug development to academia, you'll need to raise salaries, or find a lot of scientists willing to work for academic salary while doing grunt work on massive projects that will mostly likely fail.)

      To pick a more specific example, the NIH spends approximately $1.2 billion per year on aging-related research (including but not limited to Alzheimer's):

      https://www.nia.nih.gov/about/...

      Most of that will be single-investigator grants, and as anyone who has worked in basic research can tell you, the majority of the grants that are funded won't lead to any immediate treatments, although they may provide useful information in the long term. In contrast, here is an estimate of the total cost per Alzheimer's drug being $5.7 billion (including failures, and keep in mind the overwhelming bulk of that is spent by drug companies):

      https://alzres.biomedcentral.c...

      This isn't to argue that taxpayer funding of basic research isn't valuable - it's absolutely essential IMHO. But most of what it produces isn't going to lead directly to new drugs or treatments.

      Obligatory disclaimer: I do not work for a drug company, but I did receive funding from them as a government scientist, and receive a small bonus from IP licensing fees every year. Frankly it was far more trouble than it was worth; drug companies are kind of a pain in the ass to deal with, even if you only talk to the scientists.

  19. Is it morally right to force other people to pay by rsilvergun · · Score: 1

    for someone's medicine? I said "Force" there. Because if you're getting into single pay with taxes funding health care then you are effectively forcing me and everyone else to pay for their medicine. Maybe I want to, but shouldn't that be my choice? Shouldn't I decide if I'm going to give that money to a charity or not? What if I oppose the medicine being give (like the "Morning After Pill")?

    I'm asking loaded questions here. I'm in favor of single payer because it's part of civilization. And I'm in favor of forcing people to join civilization for the same reason I'm in favor of vaccinations. But I've yet to hear a compelling argument for all of this. I've yet to hear anyone give an answer to the age old "Tax and Spend Liberals". Maybe "Slash and Burn Conservative"? But even that's not as catchy or "Truthy"...

    --
    Hi! I make Firefox Plug-ins. Check 'em out @ https://addons.mozilla.org/en-US/firefox/addon/youtube-mp3-podcaster/
  20. For profit Medicine B$ by RandySmith6424 · · Score: 1

    "As Interim Chief Executive Officer, and Senior Vice President, Chief Medical Officer at SAREPTA THERAPEUTICS INC, Edward M. Kaye M.D. made $4,396,696 in total compensation. Of this total $494,585 was received as a salary, $249,704 was received as a bonus, $1,694,678 was received in stock options, $1,939,532 was awarded as stock and $18,197 came from other types of compensation. This information is according to proxy statements filed for the 2015 fiscal year." So the people that need the medicine are dying, or going into absurd debt, or paying out of their ass for this medicine. All while the CEO of the company gets a $250k bonus and makes $500k/year....

    1. Re:For profit Medicine B$ by MightyMartian · · Score: 1

      So the answer is simple. TAx the living fuck out of the man. Set a base rate where taxes are progessive, but anything over that, and the tax rate goes up to 99%.

      --
      The world's burning. Moped Jesus spotted on I50. Details at 11.
    2. Re:For profit Medicine B$ by lactose99 · · Score: 1

      You mean tax rates before Reagan broke things? Where the economy was still great and we didn't have nearly the wealth disparity we do now? Not possible

      --
      Fully licensed blockchain psychiatrist
    3. Re:For profit Medicine B$ by KingMotley · · Score: 1

      So if Edward M. Kaye made something you think is more reasonable, like...$20,000 a year ($10/hr), and your $50k drug is now let's see... (($4,396,696 - $20,000) / 7,100,000,000) is $0.0006, so it's now $49,999.9994 then you'll be happy?

    4. Re:For profit Medicine B$ by RandySmith6424 · · Score: 1

      First of all your math is terribly wrong. His yearly salary is $500k. So it would be ((494,585-20,000) / 7,100,000,000) which is 0.00007 (I think, I am not math).... Also, I am using his salary as the CEO as a arguing point toward the obvious greed that these companies live on. This company also has 5 board of directors that make a combined salary close to a million. So while millions of people suffer financial hardships on top of the physical pain, these 6 people among the thousands that make money from this company, thrive financially.

    5. Re:For profit Medicine B$ by KingMotley · · Score: 1

      My math isn't wrong, I said made $20k a year, not change his salary to $20k a year. That would mean removing stock options, and extra shares of stock, bonuses, etc. However, so your complaint is that there are people who are doing better than you? Yeah, cry me a river.

  21. Government to the rescue; post-scarcity by mi · · Score: 3, Interesting

    Perhaps the government ought to produce those orphaned drugs themselves

    Could you cite a few examples of where the government proved to be more efficient at producing a product or delivering a service, than a privately-run firm?

    drug companies that are charging prohibitive amounts to citizens

    The hate towards the drug companies is misplaced — and whether they are sinfully greedy or not is irrelevant. The simple fact is, had they not existed, the drugs would not have existed — unavailable at any price.

    If only K of something — anything, from LeBron's sneakers to life-saving medicines — is available despite there being N people desiring it, then whichever way you pick to distribute it:

    • Lottery
    • Charge the highest price at which there are still willing buyers
    • Minorities first
    • Government employees first
    • Celebrities first
    • ...

      N-K people will still not receive it — and no amount of "outrage" will help.

      The only hope for the rest is that the second method — charging whatever the market will bear — will be chosen, because then the profits (however "obscene") may be used to produce more of the stuff... Incidentally, Capitalism is all about the second method and that is why we tend to enjoy an abundance of most things — to the point, where some people are already talking about "post-scarcity".

    --
    In Soviet Washington the swamp drains you.
    1. Re:Government to the rescue; post-scarcity by Areyoukiddingme · · Score: 1

      If only K of something — anything, from LeBron's sneakers to life-saving medicines — is available despite there being N people desiring it, then whichever way you pick to distribute it:

      Lottery
      Charge the highest price at which there are still willing buyers

      blah blah blah

      I can't even be bothered to quote all this drivel. What are you babbling about? Once drug research is complete, production is ALWAYS cheap. We're talking about chemical processes here. If you want more of a drug, you just use a bigger vat to make it. For those drugs with particularly nitpicky production methods (and those are few and far between, because a significant fraction of the research is about making production cheap and easy), just buy a second small vat.

      When it comes to drugs, K >= N, always. Drugs where research hasn't progressed to the stage where production is cheap aren't even submitted to the FDA. No drug company on Earth will spin up a massively expensive, difficult production process if they have any choice. And before you jump on that, they've bought and paid for more than enough politicians to have all the choice they'll ever need.

      No, this is gouging, plain and simple. When the marketing budget is much bigger than the research budget, and the production budget is lost in the noise, it's gouging.

    2. Re:Government to the rescue; post-scarcity by mi · · Score: 1

      I can't even be bothered to quote all this drivel. What are you babbling about?

      Please, don't hate, asshole.

      No, this is gouging, plain and simple.

      No, it is not. If not for the "gougers", the drugs would not have been available. At all. Zilch. Nada. You are fully entitled to boycotting them and pretending, their product does not exist. Please, do. The sooner you pass away, the better for all concerned — including, nay beginning with (!), your closest relatives.

      --
      In Soviet Washington the swamp drains you.
    3. Re:Government to the rescue; post-scarcity by Areyoukiddingme · · Score: 1

      If not for the "gougers", the drugs would not have been available.

      Bullshit. Again. University professors did the basic biological research to understand the causes of the diseases. University professors did the initial in vitro experiments to determine what drugs might be useful. University hospitals did the first animal trials to see if the drugs would work. University hospitals did the first, second, and third level clinical trials to further refine the drugs. Only THEN does a for-profit pharmaceutical company swoop in and license the result.

      We are talking about rare drugs for rare disorders. Pharmaceutical companies do not pay for research into rare diseases. They could give a fuck about rare diseases, unless and until someone else does all the hard work for them. There's not enough market. The research they pay for is finding a way to file a bullshit patent extension for one of their existing mass market products. Then they pay more for the marketing than they did for the research.

      The sooner you pass away, the better for all concerned — including, nay beginning with (!), your closest relatives.

      Go fuck yourself you lying thieving sociopathic asshole.

    4. Re:Government to the rescue; post-scarcity by Actually,+I+do+RTFA · · Score: 3, Interesting

      Could you cite a few examples of where the government proved to be more efficient at producing a product or delivering a service, than a privately-run firm?

      The USPS. Providing libraries. Electricity (either government run or price set). Some would probably say healthcare in general (ex. Medicaid vs. private insurance).

      The simple fact is, had they not existed, the drugs would not have existed â" unavailable at any price.

      Most drug companies purchase completed drugs (often funded by the government), not develop them inhouse.

      The only hope for the rest is that the second method [Charge the highest price at which there are still willing buyers] â" charging whatever the market will bear â" will be chosen, because then the profits (however "obscene") may be used to produce more of the stuff..

      That's quite simply wrong across multiple dimensions. First, the highest price where there are still willing buyers is no where near proper profit maximization. Secondly, marginal costs on drugs are almost nothing, they're almost all fixed costs. There's no reason that there are a limited amount of pills any more than there are a limited number of CDs. Third, that "may" is troubling. Sure, it may be used for that, or simply pocketed. Since money is fungible, there's no real cause to suggest that it will directly fund the next round

      --
      Your ad here. Ask me how!
    5. Re:Government to the rescue; post-scarcity by thegarbz · · Score: 2

      efficient

      Efficient? No. Cheaper to the end user? Plenty. In many cases the lack of efficiency of a process is offset by the desire to make CEOs and corporate shareholders rich in private institutions.

  22. Re:The US subsidizes healthcare for the rest of th by jopsen · · Score: 1

    The cost of healthcare for the rest of the world will go up while it goes down for the US.

    Nope, but we might see reduction in research and development of new drugs...

    But in fairness, there is value to balancing how much money we spend on researching new drugs and how much we spend on treating people with existing drugs..Clearly, it's not cost efficient to develop drugs for rare diseases..

    Or, maybe the end result is higher government subsidies for research and development, which probably could be more efficient economically than financing drug research and development through the stock marked.

  23. Arithmetic by bill_mcgonigle · · Score: 1

    Lower the production and compliance costs or increase the number of people with the rare diseases. The second one isn't possible so the first one is mandatory. That is within the FDA's control.

    Bureaucrats will tend to want to do neither and to make everybody else pay for their phoney baloney jobs but that does nothing to improve market incentives and only winds up increasing costs further.

    --
    My God, it's Full of Source!
    OUTSIDE_IP=$(dig +short my.ip @outsideip.net)
  24. Re:The US subsidizes healthcare for the rest of th by ccguy · · Score: 1

    A little known secret: Most countries' governments arbitrarily set the price of drugs and medical devices during negotiations and force pharma and medical device manufactures to sell it at a loss (or simply not have access to that market). To make up for the R&D and marketing, they have to jack the price up in the US to make up the loss.

    Yes, this sounds like something the US would be OK with :-)

    Many of the big pharmas are European. https://www.tharawat-magazine....

    The US treats drugs as commodities, subject to supply, demand, and buyer desperation. That's all. Europe does not, at least not as much as the US would like. If the US imposes a limit on prices what will happen is that companies will be forced to be more efficient, make less money, or let new players take their place in the market. All of those options are fine by me.

  25. Re:Is it morally right to force other people to pa by MightyMartian · · Score: 1

    You understand that the American Revolutionaries never intended to set up a system where every single person had to opt-in for a tax. The issue was to have taxation with representation. You live in a representative democracy, which means that the obligation is that a majority of the elected representatives agree to the tax.

    Trying to turn this into a moral issue is bizarre, since essentially your position boils down to "I want the right to abrogate any moral obligation I have to my fellow man, and that's totally moral!"

    As it is, overall, the US has some of the worst overall health outcomes in the industrialized world, while it's health care system actually produces a larger overall drag on the national economy. So, if we're going to talk morals, you think it's somehow moral that overall people are more poorly served at greater overall cost, just because maybe you personally get to pay less?

    --
    The world's burning. Moped Jesus spotted on I50. Details at 11.
  26. Americans want everything for nothing. by wickerprints · · Score: 1

    The real reason why healthcare is so expensive in the US is because Americans want the "freedom" to have everything they want, but expect that someone else should have the responsibility of paying for it. This leads to attitudes such as:

    "I want to eat the cheapest and unhealthiest food and drink as much soda as I want, and expect my health insurance to pay for my diabetes, heart disease, morbid obesity, and metabolic syndrome, because it's my right to decide what to eat."

    "It's my right to feed my children whatever food I want. How dare the government suggest guidelines for what my kids should and should not eat. How dare they suggest I'm setting them up for a lifetime of poor dietary choices and health problems."

    "I want the best health care possible, because I paid my insurance premiums and taxes for decades."

    The broader issue here is not that orphan drugs are expensive--to be clear, they are very, very expensive--but that Americans are ignorant and uneducated, distrustful of science yet reliant on science for life-saving medications, smartphones, self-driving cars, nutritious food, clean renewable energy, and so on. They think vaccines are a government conspiracy, believe climate change is a hoax designed to prevent them from getting rich, and believe in a divine Creator that will grant them their wish to be personally wealthy if they simply have enough faith, and that if one does not have their material wishes granted, it is because they didn't give enough money to the televangelist who told them God would answer their prayers. These people complain that Obamacare is too expensive but when they get cancer, expect Medicare to pay for the chemo, radiation, and surgery.

    In that context, is it any wonder that health care is expensive? Americans are hypocrites: they preach endlessly about "personal responsibility" but when it comes to actually being personally responsible, suddenly everything is Somebody Else's Problem And I Had Nothing To Do With It.

    Drug development is expensive. It costs insane amounts of money to discover candidate compounds, then run through preclinical and clinical trials, then jump the pivotal Phase III hurdles. Orphan indications would never be addressed without giving the pharmaceutical industry an incentive to treat them. If one insists on applying a capitalist economic model to orphan drug development, this is how it looks. You can't claim to be in favor of free-market principles and in the same breath claim that this is the cause of crippling health care costs. This is what Americans ask for when they say that health care should remain a privatized system.

    1. Re:Americans want everything for nothing. by RandySmith6424 · · Score: 1

      You watch too much American "Reality TV".

  27. Hello, death panels by Trailer+Trash · · Score: 1

    In the United Kingdom, the National Institute for Health and Care Excellence (NICE) determines the cost effectiveness, or value, of newly approved drugs based on their impact on quality-adjusted life years. These determinations inform the National Health System's (NHS) treatment-coverage decisions.

    In other words, if it's too expensive to treat you and therefore not worth it, they decide you don't get the medicine. This is what folks in the US were referring to as "death panels". They're actually correct, but the reality is that in the US anybody who can't afford the drug is going to die, also.

    1. Re:Hello, death panels by currently_awake · · Score: 1

      The American insurance companies also have death panels. They choose what is covered and what isn't.

  28. Re:That's what happens when "price is no object" by myowntrueself · · Score: 2

    When someone will pay a price for a thing, that is the price of the thing. When that someone doesn't really care about the price, because they can just print more money, there is no downward pressure on the price.

    It's math, kids.

    There are people living in 'luxury apartments', paying 90% of their income into rent not because they want to live in high class apartments but because thats all that is available and its a choice between that and being homeless. Sometimes people are, literally, forced to pay through the nose for goods and services, are given no choice and have to pay the price that is demanded or face life-changing problems from which they are unlikely to recover (homelessness is a good example).

    The downward pressure ultimately becomes massive civil unrest and crime, like when in the UK you'd be hung for stealing a loaf of bread and we have the saying "May as well be hung for a sheep as for a lamb".

    --
    In the free world the media isn't government run; the government is media run.
  29. U.S. Population unfairly burden with high cost by supercell · · Score: 1

    The whole global drug development system needs to be changed. As it now the U.S. develops and the U.S. population is saddle with paying for most of the new drug research and development in the world. Once developed a drug that cost $50,000 p/year in the US will cost $800 in some other part of the globe. The whole R/D and economic system needs to evaluated. The US population is being unfairly burden with the high cost of the drugs.

    1. Re:U.S. Population unfairly burden with high cost by moeinvt · · Score: 2

      Yes. People in the USA are being forced to subsidize the development of drugs for the entire rest of the world.

      How can a drug that sells for $800 in one place cost $50,000 in the USA? Because the U.S. federal government makes it illegal to import or re-import that drug, or any prescription drugs. Repeal this ban and the price discrepancies disappear. Drug prices in the USA would fall quickly and dramatically.

      The problem isn't with the development model. The problem is government.

  30. Re:Attn Americans by blindseer · · Score: 2

    You claim that the current prices of drugs is a reflection of the free market failing to keep prices low. Here's a problem with your assessment, we don't have a free market with drugs.

    One thing is that the FDA has declared that any drug sold in the USA must get their approval, and the approval process they have is long and expensive. If you want to see prices go down then we need to see reform in the approval process. What we are talking about here are people with extremely rare diseases that threaten their lives. If the FDA simply opened the floodgates on allowing the testing then we'd have all kinds of drugs getting tested and the cheapest ones would win. As it is now drug companies have to pick and choose which ones to submit for approval for testing placing very high costs on failure, so they will spend a lot of money on R&D. Once a drug is approved for a disease research stops because the profit motive is gone. The market is small, the costs are astronomical, so the ability to profit disappears. For prices to go down people need to be able to compete in these exceedingly small markets. Or, the market needs to grow by, as a possibility, treaties that allow testing in other countries to be recognized more universally.

    Along that line of allowing drug tests to cross borders is that the FDA prevents importation of these cheap drugs without their prior approval. My sister has diabetes and was on vacation to India. She needed more insulin while there and she was able to walk into a pharmacy and buy a vial of insulin for something like 25 cents. Why does it cost something like $50 per vial here? I'm sure a lot of that has to do with FDA overhead.

    Here's a few other things that drive up drug costs. Prescription rules, if you want even a common drug for a chronic condition you will need a permission slip from a physician. Why? Can't people figure this out on their own? My sister knows what kind of insulin she needs. Another thing about diabetes treatment, I remember when disposable syringes were sold by the hundred and were just sitting on the shelf at the drug store. You want to see medical costs go down? Then let people buy these things without a government permission slip. I'm not saying that we need to remove all regulation, only that they need to be rolled back to something more reasonable. If people can buy safe and effective insulin for less than a dollar in India but it costs 50 times that in the USA then we are doing something seriously wrong.

    More laws will not fix this problem. The problem is too many laws. The drug companies would not be able to price gouge if the market wasn't so close. If you think that there is price fixing then I ask you to prove it. It takes only one drug company to step out of line to ruin the whole deal. If they are all in on the deal then the rules need to be changed to make it easier to start a drug company.

    --
    I am armed because I am free. I am free because I am armed.
  31. profit margins by ProfBooty · · Score: 2

    Check out the net profit margins on many of the big Pharma companies. They're not obscenely high for the most part. Apple for example has had a profit margin of around 20% for the past few years.

    Average profit margin in the last 5 years:
    GSK=12%
    Merck=9%
    Abbot Labs=15%
    Astrozenica 12%
    Eli Lilly 13%

    They're good for the most part, but not unbelievably amazing.

    --
    Bring back the old version of slashdot.
    1. Re:profit margins by Nunya666 · · Score: 2

      Check out the net profit margins on many of the big Pharma companies. They're not obscenely high for the most part. Apple for example has had a profit margin of around 20% for the past few years.

      Average profit margin in the last 5 years:
      GSK=12%
      Merck=9%
      Abbot Labs=15%
      Astrozenica 12%
      Eli Lilly 13%

      They're good for the most part, but not unbelievably amazing.

      Don't forget, that's after throwing away 20-40% on advertising.

      So, yes, they are unbelievably amazing.

    2. Re:profit margins by AcidPenguin9873 · · Score: 1

      Don't forget, that's after throwing away 20-40% on advertising.

      Do you have data to support your claim that the advertising money is completely useless and doesn't result in increasing sales for these companies?

    3. Re:profit margins by Highdude702 · · Score: 1

      the US market subsidizes the markets for the other, poorer nations.

  32. Re:Attn Americans by KingMotley · · Score: 1

    Sounds like you need a quick class on economics, because "If the free market is not allowed to work, and instead there is price gouging going on" are not mutually exclusive. Quite the contrary, a free market is pretty much required for price gouging to go on. You are only focused on one half of the equation (more competitors usually means lower prices), vs the other side which is anyone doing selling can (and almost always will) sell to make the most amount of profit, not necessarily the highest quantity.

  33. Who's pushing this narrative? by rsilvergun · · Score: 1

    I've seen multiple stories about how a small number of Americans are responsible for most of the healthcare costs in the last week or two. These weren't part of the general healthcare debate leading up to the failed Obamacare re-write (I refuse to call it a repeal, they didn't have the guts to do that). They started springing up about a week or two ago.

    Yeah, these stories might be true and all, but what I find disturbing is how they keep showing up all of the sudden. Coincidentally right around the time Bernie & co have a bill on the Senate floor for Medicare for All. It's pretty obvious if you're looking that somebody is firing propaganda shots off. But if you're not a news hound like me with a google feed full of politics you probably wouldn't have noticed. I'm guessing it's the insurance companies buying stories to shut down single payer, since single payer should shut them down...

    Anyway, I'd like everyone ehre to realize there's a difference between Bernie trying to talk you into single payer and somebody pushing a pro-insurance narrative on the sly. Whatever your opinion on the merits of single payer vs paid insurance just know that your actively being manipulated.

    --
    Hi! I make Firefox Plug-ins. Check 'em out @ https://addons.mozilla.org/en-US/firefox/addon/youtube-mp3-podcaster/
  34. Re:Stupid summary is STUPID by KingMotley · · Score: 2

    On the other hand, if it wasn't for those for those paying $50k in the US, there wouldn't be a drug AT ALL. The reason it is $1k in India and $50k in the US is because of that's how it is set up to maximize the return on investment. The drug companies are simply selling the drug at whatever will make them the most money, and because of the way the insurances work in the US, there are a lot of people who can get that drug at $50k. They would make a lot less money if they sold it for $1k in the US (demand won't grow 50x). Yet if they sold it for $2k in India, they would likely sell less than half of what they do at $1k.

    But your first statement is correct, it isn't a completely free market. It's a limited free market (within the US), and then limited by law (must have FDA approval), and restricted by patents. I would love to hear about a better way, but I've yet to hear one that would actually work. Most of the great "fixes" aren't well thought out and would fall apart.

  35. Re:The US subsidizes healthcare for the rest of th by Anonymous Coward · · Score: 2, Informative

    With the upcoming collapse of Obamacare

    You've been watching too much TrumpNews. The "collapse," if it happens, only refers to there being no providers on the ACA-created health insurance exchange marketplaces. We can use scary words like "explosion" but the fact of the matter is that unless and until there are ZERO policies sold on the exchanges in the ENTIRE country, we're a step ahead of where we were in 2010, and that leaves aside every other reform in the entire act.

  36. Corporate Greed is the root by sdinfoserv · · Score: 1

    No, it's greed over people pure and simple. cancer treatments that cost $100k per treatment in the US vs $3k in Canada for the same drug by the same maker.
    Arsewipes like martin shkreli and Elizabeth Holmes are not poster children, but the norm.
    The US FDA went on a war against imported Canadian drugs a few years ago to increase profit to the US pharma cartel and their paid for elected pawns to ensure profit continues to roll in.
    UW, the University of Washington is developing a cure, a real cure, for leukemia. In order to raise money for research, the rights were sold to a VC (vulture capitalist firm) who giggle with glee believing they can charge $500K per dose. Here’s the piece most people don’t realize – most health care policies contain lifetime maximums; usually $1m, $2M for the better, more expensive ones. These greedy jerks are going to consume ½ of someone’s life time’s healthcare in a single injection. Think about those implications. This is not about making health care better, more affordable, or improving the lives of people, this is purely about extorting life and death so a very, very few can have bigger houses and private jets. Welcome to ‘Merica 2.0.

  37. Read my post again by rsilvergun · · Score: 1

    they're not doing the expensive part of that 2.5 billion. You are. With your Tax Payer dollars. Anyone who says they're spending that kind of money is just using clever accounting. Kinda like how Return of the Jedi lost money at the box office.

    --
    Hi! I make Firefox Plug-ins. Check 'em out @ https://addons.mozilla.org/en-US/firefox/addon/youtube-mp3-podcaster/
    1. Re:Read my post again by the+gnat · · Score: 1

      This is the kind of circular argument that's impossible to refute. "Show me the numbers!" "Here are the numbers!" "No, those don't support my predetermined conclusion, so they must be fake." It's exactly like the Trump administration's attitude towards climate science, to pick one recent example. But whatever, the same strategy worked out so well for the fossil fuel interests that I guess I shouldn't be surprised that other ideologues have latched onto it.

  38. Re:Attn Americans by amicusNYCL · · Score: 4, Interesting

    Here's a problem with your assessment, we don't have a free market with drugs.

    I know, that's my point. I said that if the free market was working, then we would see more competition and lower prices. The fact that we don't means that it is not working. The fact that no one is coming in to undercut prices on generic drugs that are not encumbered by patents is indicative of the fact that the free market is not working here. It might be evidence of collusion and price-fixing, or a situation making it impossible for competitors to enter the market.

    Prescription rules, if you want even a common drug for a chronic condition you will need a permission slip from a physician. Why? Can't people figure this out on their own?

    I understand that problem well. My wife is from Brazil, when we are there she can walk into any pharmacy and get whatever she wants, she can even consult with the people working there. There are certain limitations on what they're allowed to do, but they can sell her any of the drugs they have there. Many of those drugs are not even available in the US even though they do not have patents and are generic drugs. She can't get steroids that she needs for inflammation and other issues, and she can't even get the drug that works to get rid of her headaches without going to Brazil and getting it straight from the pharmacy without ever needing to see a doctor. She feels lied to after coming here and realizing that she cannot get the quality of care that she is used to from living in other countries, and the reason seems to be money, like so many of our other problems. So many people have their hands in the pie and what gets lost is actually providing good quality care to people who need it, even if it only means making drugs readily available like they are in other countries. She knows exactly what she needs, what works and what doesn't, and she simply can't get what she needs here. She feels lied to after hearing how great the US was supposed to be, and then getting here and realizing that it's all about money, and if someone can make money restricting access to health care then that's what they're going to do.

    More laws will not fix this problem. The problem is too many laws.

    Which laws do you think need to be removed in order to fix these issues?

    If you think that there is price fixing then I ask you to prove it.

    Really? You want evidence of a price-fixing scheme in a trillion-dollar industry? Well let me just hit Google, I'm sure there are signed documents online that will clear that right up.

    --
    "Our two-party system is like a bowl of shit looking at itself in a mirror." - Lewis Black
  39. Re:Attn Americans by amicusNYCL · · Score: 1

    So you're suggesting that if everyone is selling a certain medication at $30 per pill in the US, and that this pill costs less than a dollar to manufacturer, then if someone enters the market and sets their price at $20 per pill, that they aren't going to start raking in cash? Why would anyone buy the exact same thing for 50% more? The fact that profits are so high on pharmaceuticals indicates that there is plenty of room for a competitor to set a lower price and make a huge amount of money on quantity. But, hey, obviously I don't understand economics. I do understand the difference in prices for drugs in the US and other countries though, I have plenty of first-hand experience on that.

    --
    "Our two-party system is like a bowl of shit looking at itself in a mirror." - Lewis Black
  40. Re: Wait! - Why is advertising so damn expensive? by duranaki · · Score: 1

    Haven't seen it mentioned yet, so I'll chime in. It only takes a bit of T.V. watching to notice that nearly every single drug commercial is actually TWO commercials. One to promote the drug and a follow-on spot to list every single side effect and remind potential customers they should tell their Dr. about their medical conditions prior to getting them to prescribe the drug. This seems to more or less double the cost of all drug-based advertising (even print ads must be larger to include all the disclaimers and fine print) while adding no value. You HAVE to talk to your Dr. to get the damn prescription and the Dr./Pharmacy has to inform you of the side effects. Imagine how much less they'd have to spend if the rules simply stated that all side effects and cautionary tales must be published on the company websites, rather than broadcast along side every advertisement.

  41. deflazacort costs $2000 or less in Canada/EU by lquam · · Score: 1

    That's a terrible example for this article as this was a drug that had been around for decades that just got approved in the US and is dirt cheap everywhere else. For the cost of doing trials and getting FDA approval, Marathon gets a 45x markup. Whereas previously, patients could buy this drug from overseas, now that it's approved by the FDA, they can no longer do that. So they have to pony up the $89K (minus whatever discounts Marathon offers to try and appease the mob). That's BS. The reform has to start at the FDA. If a drug is approved in a place like Canada, where I'm sure they're not just passing out hemlock and saying this might cure something, the process here should at the very least be shortened for approval and if the drug is already available from an existing company(ies), then they should not be handing out these sweetheart deals, like the one to Marathon, to essentially gouge all Americans with these ridiculous prices. The FDA and the Congress are complicit with the drug industry lobbyists for creating this environment where America pays far more for every drug than in the rest of the world. We're floating Big Pharma's profits and their marketing budgets because no one in Washington DC has the will to stand up and protect the American consumer.

  42. Re:The US subsidizes healthcare for the rest of th by currently_awake · · Score: 1

    You are suggesting drug prices in the US are related in any way to drug prices in other countries. The drug companies set their prices to maximize revenue, they make a profit in every country or they abandon that country.

  43. Truvada PrEP // Absurdly high prices for generics by WolphFang · · Score: 1

    Did you know that HIV transmission can be prevented with a pill?

    Would it not be a good thing to HALT the spread of HIV (or at least slow its spread to below the threshold for it to remain in the population long term)?

    Sort of like the effort put into to stopping smallpox and making polio rare?

    Truvada PrEP is estimated to be greater than 99% effective.

    Across the US border it costs about $70. But here? Something like $4,000+, unless your insurance covers it, then $600+.

    Putting two generic medicines into a single pill warrants x50 price increase and a patent to cover that?

    --
    leather-dog muksihs
    Blog: @muksihs
  44. Re:The US subsidizes healthcare for the rest of th by currently_awake · · Score: 2

    We build and maintain roads using taxes because it's expensive, has a large benefit to society, and is hard to pay for without destroying those benefits. We should do the same with drugs- all research, production, and distribution done by government. Doing so will eliminate the high risk to corporations (failed drugs=lost money), and ensure our healthcare dollars are only spent on costs not private helicopters.

  45. Ok, by rsilvergun · · Score: 1

    show me your #s. I'm waiting... It's pretty easy to prove the point that they spend more on marketing than R&D with a google search. So show me a single, low user drug with 2.5 billion invested in it where the money came from the drug companies pockets.

    Oh, and I've got family with cancer. The drugs that kept them alive were invented in Europe by the European governments because not a single US company would spend a dime on it.

    --
    Hi! I make Firefox Plug-ins. Check 'em out @ https://addons.mozilla.org/en-US/firefox/addon/youtube-mp3-podcaster/
    1. Re:Ok, by david_thornley · · Score: 1

      The low-user drugs don't tend to pay very well, so the companies need more government support to make it profitable. This is because of a deliberate government decision to finance these drugs.

      --
      "When you have eliminated the unacceptable, whatever is left, however improbable, must be the truthiness" - Holmes
    2. Re:Ok, by the+gnat · · Score: 1

      The drugs that kept them alive were invented in Europe by the European governments because not a single US company would spend a dime on it.

      [citation needed]

  46. Re:The US subsidizes healthcare for the rest of th by iris-n · · Score: 1

    Poor pharmaceutical companies, they have to jack up the price! Otherwise they wouldn't have such fabulous profit margins, or be able to spend such an incredible amount of money in marketing! Imagine the horror!

    --
    entropy happens
  47. what the unholy &^%$#!!!! by morethanapapercert · · Score: 2

    $89,000/yr for deflazacort? Big Pharm clearly has the US health industry blindfolded, bent over and reamed but good doesn't it? My son has Duchenne's Muscular Dystrophy and is taking deflazacort for it. It hasn't been approved for general prescription here in Canada, but getting approval for it to treat DMD is a straightforward rubber stamp through the exceptional access program. Because it isn't formally approved, we have to pay for it and then get reimbursed for it, Also because it's an EAP drug, we're paying only a little over wholesale. Currently we pay 85$ for a three month supply, or 340/yr. That includes shipping from the pharmacy associated with the research and teaching hospital my son is being treated by.

    --
    I need a wheelchair van for my son. Help me get the word out. https://www.gofundme.com/wheelchair-van-for-jj
    1. Re:what the unholy &^%$#!!!! by cam312 · · Score: 1

      $89,000/yr for deflazacort? Big Pharm clearly has the US health industry blindfolded, bent over and reamed but good doesn't it? My son has Duchenne's Muscular Dystrophy and is taking deflazacort for it. It hasn't been approved for general prescription here in Canada, but getting approval for it to treat DMD is a straightforward rubber stamp through the exceptional access program. Because it isn't formally approved, we have to pay for it and then get reimbursed for it, Also because it's an EAP drug, we're paying only a little over wholesale. Currently we pay 85$ for a three month supply, or 340/yr. That includes shipping from the pharmacy associated with the research and teaching hospital my son is being treated by.

      1) Another Canadian DMD dad here. I almost hope that Deflazacort doesn't get approved in Canada. I couldn't afford it then! 2) My son is eligible for Etiplirsen - but there's no way I can afford $300k+ per year. My health care insurance only works on drugs available in Canada. 3) I've testified at the FDA Adcom for a drug in this rare disease world. What a headache. The degree of profit mongering, paperwork generating hurdles that are out there are mind blowing. I don't know if it's corruption, the free market gone wild, self-important bureaucracy, or if the circus was in town. But I can tell you that the FDA process ESPECIALLY for rare drugs is screwed up. I don't have answers. I do have a couple of thoughts though. 1) Hug your kids. Time can be short. 2) Point all the fingers you want at the Canadian medical system - I'm not complaining. (and I see a LOT more of it than 99.99% of the people whining and complaining about it) For the most part - I get to make life altering decisions for my family without having to worry about the bill.

    2. Re:what the unholy &^%$#!!!! by strikethree · · Score: 1

      $89,000/yr for deflazacort?
      ...
      Currently we pay 85$ for a three month supply, or 340/yr.

      Unbridled capitalism is awesome eh? I could not possibly see any good coming from regulating it at all. ggwp

      --
      "Someone needs to talk to the tree of liberty about its ghoulish drinking problem." by ohnocitizen
  48. Re:Attn Americans by KingMotley · · Score: 1

    No, I am not suggesting that because it isn't that simple. I'm going to try and put this in a way that hopefully you will understand (with my very limited knowledge of lawyering, and I'll assume you are a lawyer based on your name). Presenting a case in trial should be free, because I have the choice of multiple lawyers, and it costs absolutely nothing to talk in front of a judge and in some cases you can get a public defender which is free. That doesn't happen for the same reasons drugs that cost $1 to manufacture aren't cheaper. Now this is the point where you step in and tell me all the reasons why you charge for your services, why it isn't free, why you cost more than the public defender...

    As for drug companies, you can't make a pill for $1. You can't make a single pill for $1,000, or even $10,000. You can however, possibly make a million pills for 1 million dollars. There are set up fees, and QA testing, drug testing, packaging (and testing), and... so on and so on that all must go through the FDA. Even generic drugs. You have to prove that the delivery system is the same, at the same dosage, and delivers the active ingredients at the same rate as another generic, or the brand name product. You have to prove your manufacturing process is within a given tolerance (not every pill has the EXACT same quantity of active ingredient, even for brand name drugs). Then you have to market it, sign agreements with warehouses, and packaging companies, and eventually someone to put it where people can actually buy it.

    So no, if it costs $2m to get all that stuff done, and then x% after that goes to other expenses, if you can only sell 10,000 pills per year, you will not make a killing at selling them for $20 each. It is complicated, and it is a long process (even when lawyers don't get involved), and there is significant risk in trying to bring even a generic drug to market, but there is so much "profit" to be made, then why don't you go do it yourself and become a bajillionaire?

  49. Britain is an aweful model by superwiz · · Score: 1

    Before Obamacare, US had 60% cancer survival rate. And even higher rates for some of the better understood and more frequently screened forms of cancer. Britain's cancer survival rate at the same time was 30%. So I would not use Britain as a model for how to deal with expensive rare treatments.

    --
    Any guest worker system is indistinguishable from indentured servitude.
  50. Patents and free market by theguyfromsaturn · · Score: 1

    Shouldn't the government have an obligation to limit the market price of such drugs? I'm sure the rapacious companies charging exuberant amounts for the drugs would yell "free market" to excuse their prices, but the truth is that a drug under anti-competitive patent protection does not exist in a free market. Since the government provides the protection against competition to the manufacturer, shouldn't the same government, whose primary obligation is towards its flesh and blood citizens, and not its corporate citizens, have the obligation to regulate the price of drugs used for the treatment of illness? To lose the price restriction, a company should be obligated to lose the protection against competition. That only seems fair, and a proper use of the patent system. Right now it seems to be broken and abused by the industry.

    --
    I like my dinosaurs feathery, and my pterosaurs hairy (or is it pycnofibery?)
  51. Re:Attn Americans by amicusNYCL · · Score: 1

    No, I'm not a lawyer. I understand that it costs money to go through the process. I also understand that there are medications that cost $0.18 per dose in other countries, and $30 per dose here (or $89,000 for three months here, versus a few hundred dollars if you're in India or Egypt).

    but there is so much "profit" to be made, then why don't you go do it yourself and become a bajillionaire?

    If I had the resources to start that I would, believe me. I would find generic drugs that aren't under patent and I would go through the process to manufacture and market them and sell them for a price that is more on par with the rest of the world. I don't have the resources to do that right now, but even so, the goal would not be to become a bajillionaire, I would be happy to break even and see more people who need medications have access to them. In the US no one is going to do anything if they can't make a buck off it, and if they can make $1 then shit, why not crank up the price and make $10,000, right? How many stories have come out over the past few years of pharmaceutical companies raising drug prices by hundreds or thousands of percentage points? What happened, did it all of a sudden get so much more expensive to make them? Did they just get the lawyer bills?

    --
    "Our two-party system is like a bowl of shit looking at itself in a mirror." - Lewis Black
  52. Re:yes, government health care is a disaster by blindseer · · Score: 1

    I have a similar story. I wouldn't say that the VA tried to kill me but they seemed to have little sympathy for my pain.

    The VA isn't the only failure in government medicine. Look at the Indian Health Service, Medicare/Medicaid, and various state agencies. It's not just government but also the insurance agencies. I hear horror stories from people about not getting the medicine they need from hospitals because insurance won't pay what they charge, but they can go to a drug store and get the same stuff the shelf for pocket change.

    Hospitals will charge $20 for a Tylenol because the insurance companies will pay it. That's not for a bottle of Tylenol, that's for a single pill. That's what happens when we create layers of bureaucracy between the patients and care providers.

    --
    I am armed because I am free. I am free because I am armed.
  53. how to lower the cost of drugs by Goldsmith · · Score: 1

    As multiple other people here have posted, the pharma industry spends at least $2.5B in R&D per new drug. Also, almost all of that is spent in the US, where the vast majority of new drugs are researched. To attract talent, pharma companies generally put their R&D in desirable places to live, have nice facilities, and pay good salaries. When you have a team of ~1000 scientists and doctors working for 5-10 years on a drug, you're going to spend a LOT of money. Just the cost of capital to develop a drug is staggering. The easy answer is to pay people less, and convince them to work in cheaper facilities... The rest of the world tried that and now virtually all the drugs are developed in the US.

    One way to do fix this is to focus on spinning out R&D efforts as startup companies. This places the financial risk on the scientists doing the work, but also gives them much greater rewards for success, and an incentive to keep costs low. That's the giant problem with pharma development and marketing right now: no one has any real incentives to keep the costs down.

    There are R&D grants for orphan drug development, and there are patient advocacy groups that help with clinical trials. We need to be able to get to a future where a "successful" small pharma effort is one with $5-10M of annual revenue.

  54. This reality has a conservative bias by slashdot_commentator · · Score: 1

    Hate to say it, but people don't seem to realize that health care costs money, and it may even require not financially covering certain treatments, like organ transplants, rare diseases, and MRIs for diagnosis ass-covering. If the American public cannot concede to common sense, no form of nationalized health insurance program will be fiscally plausible.

    --
    There is no America. There is no democracy. There is only IBM and AT&T and DuPont, Dow, General Electric, and Exxon
  55. Re: Wait! - Why is advertising so damn expensive? by AutodidactLabrat · · Score: 1

    Much of what costs isn't in advertising to the public
    It's in fishing jaunts for Dr.'s, payola to Bureaucrats, "Free" medical symposia to peddle the latest nostrum and "Free" contributions to Legislators

  56. Re:You really really should care by war4peace · · Score: 1

    That's irrelevant.
    If you would have to pay a dollar extra per year to save some people, would you be willing to do it?
    Besides, it's all a point-of-view discussion. If you're the one being sick, your view on how it should be radically changes.

    --
    ...gis sdrawkcab (usually not responding to ACs; don't bother posting as AC)
  57. Re:Attn Americans by amicusNYCL · · Score: 1

    She doesn't take opiates for anything, but she does have a genetic disorder and several other chronic conditions. But, hey, thanks for the internet diagnosis.

    --
    "Our two-party system is like a bowl of shit looking at itself in a mirror." - Lewis Black
  58. Re:The US subsidizes healthcare for the rest of th by jopsen · · Score: 1

    Communist :) hehe

    But yes, more government funding for research is the best way to keep drug costs down. IMO we don't have to do everything in the public sector, but finding a balance... Notably reducing the barrier to entry for new drug companies by making funds available, funding basic research with open publication, limiting patents, and using patents from publicly funded research to the benefit of the public.